| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Fang Q, Cao Y, Oo TH, Zhang C, Yang M, Tang Y, Wang M, Zhang W, Zhang L, Zheng Y, Li W, Meng F. Overexpression of Enhances Resistance against to Soybean Pod Borer () in Soybean. Plants (Basel, Switzerland). 13. PMID 38475476 DOI: 10.3390/plants13050630 |
0.01 |
|
| 2024 |
Arai H, Yang Y, Baca Y, Millstein J, Denda T, Ou FS, Innocenti F, Takeda H, Kubota Y, Doi A, Horie Y, Umemoto K, Izawa N, Wang J, Battaglin F, ... ... Zhang W, et al. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer. European Journal of Cancer (Oxford, England : 1990). 201: 113914. PMID 38359495 DOI: 10.1016/j.ejca.2024.113914 |
0.01 |
|
| 2024 |
Battaglin F, Baca Y, Millstein J, Yang Y, Xiu J, Arai H, Wang J, Ou FS, Innocenti F, Mumenthaler SM, Jayachandran P, Kawanishi N, Lenz A, Soni S, Algaze S, ... Zhang W, et al. and gene expression in colorectal cancer: comprehensive profiling and clinical value. Journal For Immunotherapy of Cancer. 12. PMID 38212126 DOI: 10.1136/jitc-2023-007939 |
0.01 |
|
| 2024 |
Zhang W, Zheng J, Ren Z, Wang J, Luo J, Wang Y, Tao X, Liu T. Anode-Free Sodium Metal Pouch Cell Using Cu p Nanowires In-Situ Grown on Current Collector. Advanced Materials (Deerfield Beach, Fla.). e2310347. PMID 38174663 DOI: 10.1002/adma.202310347 |
0.01 |
|
| 2023 |
Zhang W, Lin J, Yuan Z, Lin Y, Shang W, Chin LK, Zhang M. Terahertz Metamaterials for Biosensing Applications: A Review. Biosensors. 14. PMID 38275304 DOI: 10.3390/bios14010003 |
0.01 |
|
| 2023 |
Lu X, Mai M, Tan W, Zhang M, Xie J, Lu Y, Niu XL, Zhang W. Identification and fungicide sensitivity of (Ascomycota, Amphisphaeriaceae), a new species causing tar spot of in southern China. Mycokeys. 100: 205-232. PMID 38098976 DOI: 10.3897/mycokeys.100.112128 |
0.01 |
|
| 2023 |
Zhang W, Lin J, Zheng Z, Gao Y, Tao J, Shang W, Zhang M. A One-Bit Programmable Multi-Functional Metasurface for Microwave Beam Shaping. Micromachines. 14. PMID 38004867 DOI: 10.3390/mi14112011 |
0.01 |
|
| 2023 |
Tang P, Ali K, Khizar H, Ni Y, Cheng Z, Xu B, Qin Z, Zhang W. Endoscopic versus minimally invasive surgical approach for infected necrotizing pancreatitis: a systematic review and meta-analysis of randomized controlled trials. Annals of Medicine. 55: 2276816. PMID 37930932 DOI: 10.1080/07853890.2023.2276816 |
0.01 |
|
| 2023 |
Song Z, Wang B, Zhang W, Zhu Q, Elezzabi AY, Liu L, Yu WW, Li H. Fast and Stable Zinc Anode-Based Electrochromic Displays Enabled by Bimetallically Doped Vanadate and Aqueous Zn/Na Hybrid Electrolytes. Nano-Micro Letters. 15: 229. PMID 37847343 DOI: 10.1007/s40820-023-01209-z |
0.01 |
|
| 2023 |
Ding L, Yu X, Zhang R, Qian J, Zhang W, Wu Q, Zhou L, Yang Z, Zheng S. Correction: Ding et al. Full-Right Full-Left Split Liver Transplantation for Two Adult Recipients: A Single-Center Experience in China. 2023, , 3782. Journal of Clinical Medicine. 12. PMID 37763050 DOI: 10.3390/jcm12185991 |
0.01 |
|
| 2023 |
Zheng X, Yang J, Wang A, Zhang Y, Song Y, Lin Z, Jia X, Feng Z, Zeng C, Zhang W. Occurrence of Anthracnose Caused by on in Southern China. Plant Disease. PMID 37700470 DOI: 10.1094/PDIS-02-23-0337-PDN |
0.01 |
|
| 2023 |
Zhang M, Li Q, Zhang W, Yang Y, Dong Q, Gu J. Identification and Validation of Genes Associated with Copper Death in Oral Squamous Cell Carcinoma based on Machine Learning and Weighted Gene Co-expression Network Analysis. Journal of Stomatology, Oral and Maxillofacial Surgery. 101561. PMID 37451513 DOI: 10.1016/j.jormas.2023.101561 |
0.01 |
|
| 2023 |
Ding L, Yu X, Zhang R, Qian J, Zhang W, Wu Q, Zhou L, Yang Z, Zheng S. Full-Right Full-Left Split Liver Transplantation for Two Adult Recipients: A Single-Center Experience in China. Journal of Clinical Medicine. 12. PMID 37297977 DOI: 10.3390/jcm12113782 |
0.01 |
|
| 2023 |
Jia X, Zheng X, Damm U, Lu X, Niu XL, Feng Y, Zhang W. , a new species causing leaf streak disease of in southern China. Plant Disease. PMID 37272043 DOI: 10.1094/PDIS-02-23-0383-SR |
0.01 |
|
| 2023 |
Wu LL, Yuan SF, Lin QY, Chen GM, Zhang W, Zheng WE, Lin HL. Construction and validation of risk model of EMT-related prognostic genes for kidney renal clear cell carcinoma. The Journal of Gene Medicine. e3549. PMID 37271571 DOI: 10.1002/jgm.3549 |
0.01 |
|
| 2023 |
Li Q, Wen N, Zhang W, Yu L, Shen J, Li S, Lv Y. Preparation of g-CN/TCNQ Composite and Photocatalytic Degradation of Pefloxacin. Micromachines. 14. PMID 37241565 DOI: 10.3390/mi14050941 |
0.01 |
|
| 2023 |
Li R, Ren C, Wu L, Zhang X, Mao X, Fan Z, Cui W, Zhang W, Wei G, Shu D. Fertilizing-induced alterations of microbial functional profiles in soil nitrogen cycling closely associate with crop yield. Environmental Research. 231: 116194. PMID 37217131 DOI: 10.1016/j.envres.2023.116194 |
0.01 |
|
| 2023 |
Bao X, Zhang W, Zhao S, Wu N, Yu C, Zhao J, Zheng W. Crack Damage Propagation and Morphology Distribution of Hydraulic Electric Pulse Fractured Coal. Acs Omega. 8: 16032-16046. PMID 37179627 DOI: 10.1021/acsomega.2c08178 |
0.01 |
|
| 2023 |
Zhang Y, Xiang S, Han Y, Guo X, Zhang W, Tan Q, Han G, Hao Y. BP-based supervised learning algorithm for multilayer photonic spiking neural network and hardware implementation. Optics Express. 31: 16549-16559. PMID 37157731 DOI: 10.1364/OE.487047 |
0.01 |
|
| 2023 |
Huang Y, Zhang W, Xu C, Li Q, Zhang W, Xu W, Zhang M. Presence of PD-1 similarity genes in monocytes may promote the development of type 1 diabetes mellitus and poor prognosis of pancreatic cancer. Bmj Open Diabetes Research & Care. 11. PMID 37130628 DOI: 10.1136/bmjdrc-2022-003196 |
0.01 |
|
| 2023 |
Yang J, Li M, Zhang W, Sun J, Feng W, Zhao J, He Y, Gong D, Hu M. First report of causing leaf spot on in China. Plant Disease. PMID 37081633 DOI: 10.1094/PDIS-11-22-2702-PDN |
0.01 |
|
| 2023 |
Ma L, Yang L, Li L, Zhang W, Cheng Y, Wang L, Zhou X, Lv Y, Liu M. Photodegradation of fleroxacin by g-CN/PPy/Ag and HPLC-MS/MS analysis of degradation pathways. Rsc Advances. 13: 11912-11918. PMID 37077267 DOI: 10.1039/d3ra01485a |
0.01 |
|
| 2023 |
Yin H, Xiao H, Qin R, Chen J, Tan F, Zhang W, Zhao J, Zeng L, Hu Y, Pan F, Lei P, Yuan S, Qian L, Su Y, Zhang Z. Lattice Strain Mediated Reversible Reconstruction in CoMoO·0.69HO for Intermittent Oxygen Evolution. Acs Applied Materials & Interfaces. PMID 37058142 DOI: 10.1021/acsami.3c00544 |
0.01 |
|
| 2023 |
Chen Y, Liu L, Rao Y, Zhang X, Zhang W, Jin X. Identifying the "Dangshan" Physiological Disease of Pear Woolliness Response via Feature-Level Fusion of Near-Infrared Spectroscopy and Visual RGB Image. Foods (Basel, Switzerland). 12. PMID 36981105 DOI: 10.3390/foods12061178 |
0.01 |
|
| 2023 |
Jiang X, Lin J, Shangguan C, Wang X, Xiang B, Chen J, Guo H, Zhang W, Zhang J, Shi Y, Zhu J, Yang H. Intrinsic RIG-I restrains STAT5 activation to modulate anti-tumor activity of CD8+ T cells. The Journal of Clinical Investigation. PMID 36927693 DOI: 10.1172/JCI160790 |
0.01 |
|
| 2023 |
Huang Y, Zhang W, Li Q, Wang Z, Yang X. Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. Scientific Reports. 13: 3661. PMID 36871072 DOI: 10.1038/s41598-023-30865-9 |
0.01 |
|
| 2023 |
Hopmann E, Zhang W, Li H, Elezzabi AY. Advances in electrochromic device technology through the exploitation of nanophotonic and nanoplasmonic effects. Nanophotonics. 12: 637-657. PMID 36844468 DOI: 10.1515/nanoph-2022-0670 |
0.01 |
|
| 2023 |
Wang J, Millstein J, Yang Y, Stintzing S, Arai H, Battaglin F, Kawanishi N, Soni S, Zhang W, Mancao C, Cremolini C, Liu T, Heinemann V, Falcone A, Shen L, et al. Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials. Eclinicalmedicine. 57: 101827. PMID 36816347 DOI: 10.1016/j.eclinm.2023.101827 |
0.01 |
|
| 2023 |
Li G, Lv K, Cheng Q, Xing H, Xue W, Zhang W, Lin Q, Ma D. Enhanced Bacterial-Infected Wound Healing by Nitric Oxide-Releasing Topological Supramolecular Nanocarriers with Self-Optimized Cooperative Multi-Point Anchoring. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2206959. PMID 36793143 DOI: 10.1002/advs.202206959 |
0.01 |
|
| 2023 |
Liang J, Gao G, Zhong R, Liu B, Christensen MJ, Ju Y, Zhang W, Li Y, Li C, Zhang X, Nan Z. Effect of Endophyte on Seed-Borne Microbes and Seed Metabolites in . Microbiology Spectrum. e0135022. PMID 36786621 DOI: 10.1128/spectrum.01350-22 |
0.01 |
|
| 2023 |
Zhang W, Yang X, Wang J, Zheng J, Yue K, Liu T, Wang Y, Nai J, Liu Y, Tao X. Rapidly Constructing Sodium Fluoride-Rich Interface by Pressure and Diglyme-Induced Defluorination Reaction for Stable Sodium Metal Anode. Small (Weinheim An Der Bergstrasse, Germany). e2207540. PMID 36755179 DOI: 10.1002/smll.202207540 |
0.01 |
|
| 2023 |
Wang J, Xiu J, Farrell A, Baca Y, Arai H, Battaglin F, Kawanishi N, Soni S, Zhang W, Millstein J, Shields AF, Grothey A, Weinberg BA, Marshall JL, Lou E, et al. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study. The Lancet. Oncology. PMID 36681091 DOI: 10.1016/S1470-2045(22)00783-5 |
0.01 |
|
| 2023 |
Chen X, Jiang Z, Tai Q, Shen C, Rao Y, Zhang W. Construction of a photosynthetic rate prediction model for greenhouse strawberries with distributed regulation of light environment. Mathematical Biosciences and Engineering : Mbe. 19: 12774-12791. PMID 36654021 DOI: 10.3934/mbe.2022596 |
0.01 |
|
| 2023 |
Jayachandran P, Battaglin F, Strelez C, Lenz A, Algaze S, Soni S, Lo JH, Yang Y, Millstein J, Zhang W, Shih JC, Lu J, Mumenthaler SM, Spicer D, Neman J, et al. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions. Oncogene. PMID 36650218 DOI: 10.1038/s41388-022-02584-4 |
0.01 |
|
| 2022 |
Zhang J, Liu L, Zhang W, Li X, Zhao C, Li S, Li J, Le TD. miRspongeR 2.0: an enhanced R package for exploring miRNA sponge regulation. Bioinformatics Advances. 2: vbac063. PMID 36699386 DOI: 10.1093/bioadv/vbac063 |
0.01 |
|
| 2022 |
Gao J, Zhang W, Yang C, Wang R, Shao S, Li J, Zhang L, Li Z, Liu S, Si W. Comparative Study on International Research Hotspots and National-Level Policy Keywords of Dynamic Disaster Monitoring and Early Warning in China (2000-2021). International Journal of Environmental Research and Public Health. 19. PMID 36429838 DOI: 10.3390/ijerph192215107 |
0.01 |
|
| 2022 |
Zhang W, Lin J, Fang X, Lin Y, Wang K, Zhang M. An Active Electromagnetically Induced Transparency (EIT) Metamaterial Based on Conductive Coupling. Materials (Basel, Switzerland). 15. PMID 36295435 DOI: 10.3390/ma15207371 |
0.01 |
|
| 2022 |
Suprono MS, Savignano R, Won JB, Lillard S, Zhong Z, Ahmed A, Roque-Torres G, Zhang W, Oyoyo UB, Richardson P, Caruso J, Handysides R, Li Y. Evaluation of microbial air quality and aerosol distribution in a large dental clinic. American Journal of Dentistry. 35: 268-272. PMID 36261408 |
0.01 |
|
| 2022 |
Zhang W, Luo M, Xiong B, Liu X. Upregulation of Metallothionein 1 G (MT1G) Negatively Regulates Ferroptosis in Clear Cell Renal Cell Carcinoma by Reducing Glutathione Consumption. Journal of Oncology. 2022: 4000617. PMID 36204178 DOI: 10.1155/2022/4000617 |
0.01 |
|
| 2022 |
Battaglin F, Jayachandran P, Strelez C, Lenz A, Algaze S, Soni S, Lo JH, Yang Y, Millstein J, Zhang W, Roussos Torres ET, Shih JC, Mumenthaler SM, Neman J, Lenz HJ. Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment. Oncogene. PMID 36182970 DOI: 10.1038/s41388-022-02479-4 |
0.01 |
|
| 2022 |
Song X, Liang H, Huang R, Ke C, Tao B, Zhang W. Mechanism underlying the response of fungi and their Fusarium symbiotic networks to the rotations of soybean and corn. Fungal Biology. 126: 609-619. PMID 36008052 DOI: 10.1016/j.funbio.2022.07.007 |
0.01 |
|
| 2022 |
Zhang W, Zhang X. The effect of ultrasound on synthesis and energy storage mechanism of TiCTx MXene. Ultrasonics Sonochemistry. 89: 106122. PMID 35981435 DOI: 10.1016/j.ultsonch.2022.106122 |
0.01 |
|
| 2022 |
Xu M, Xu D, Dong G, Ren Z, Zhang W, Aji T, Zhao Q, Chen X, Jiang T. The Safety and Efficacy of Nanosecond Pulsed Electric Field in Patients With Hepatocellular Carcinoma: A Prospective Phase 1 Clinical Study Protocol. Frontiers in Oncology. 12: 869316. PMID 35912221 DOI: 10.3389/fonc.2022.869316 |
0.01 |
|
| 2022 |
Song X, Huang L, Li Y, Zhao C, Tao B, Zhang W. Characteristics of Soil Fungal Communities in Soybean Rotations. Frontiers in Plant Science. 13: 926731. PMID 35812925 DOI: 10.3389/fpls.2022.926731 |
0.01 |
|
| 2022 |
Liu BC, Chen JY, Zhang WJ, Huang YZ, Zhao YQ. First Report of Corynespora cassiicola Causing Leaf spot of Strobilanthes cusia in China. Plant Disease. PMID 35802128 DOI: 10.1094/PDIS-03-22-0635-PDN |
0.01 |
|
| 2022 |
Wang J, Xiao Y, Loupakis F, Stintzing S, Yang Y, Arai H, Battaglin F, Kawanishi N, Jayachandran P, Soni S, Zhang W, Mancao C, Cremolini C, Liu T, Heinemann V, et al. Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials. European Journal of Cancer (Oxford, England : 1990). 172: 22-30. PMID 35749909 DOI: 10.1016/j.ejca.2022.05.016 |
0.01 |
|
| 2022 |
Millstein J, Battaglin F, Arai H, Zhang W, Jayachandran P, Soni S, Parikh AR, Mancao C, Lenz HJ. fdrci: FDR confidence interval selection and adjustment for large-scale hypothesis testing. Bioinformatics Advances. 2: vbac047. PMID 35747247 DOI: 10.1093/bioadv/vbac047 |
0.01 |
|
| 2022 |
Yue H, Banerjee S, Liu C, Ren Q, Zhang W, Zhang B, Tian X, Wei G, Shu D. Fertilizing-induced changes in the nitrifying microbiota associated with soil nitrification and crop yield. The Science of the Total Environment. 841: 156752. PMID 35718181 DOI: 10.1016/j.scitotenv.2022.156752 |
0.01 |
|
| 2022 |
Arai H, Millstein J, Yang Y, Stintzing S, Wang J, Battaglin F, Kawanishi N, Jayachandran P, Soni S, Zhang W, Heinemann V, Lenz HJ. Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial. Clinical Colorectal Cancer. PMID 35710481 DOI: 10.1016/j.clcc.2022.05.005 |
0.01 |
|
| 2022 |
Zhang M, Wang Z, Zheng Y, Zhu B, Zhang B, Fang X, Shang W, Zhang W. Manipulation of Elastic Instability of Viscoelastic Fluid in a Rhombus Cross Microchannel. Polymers. 14. PMID 35683826 DOI: 10.3390/polym14112152 |
0.01 |
|
| 2022 |
Shen X, Shi G, Ren H, Zhang W. Biomimetic Vision for Zoom Object Detection Based on Improved Vertical Grid Number YOLO Algorithm. Frontiers in Bioengineering and Biotechnology. 10: 905583. PMID 35669053 DOI: 10.3389/fbioe.2022.905583 |
0.01 |
|
| 2022 |
Puccini A, Poorman K, Catalano F, Seeber A, Goldberg RM, Salem ME, Shields AF, Berger MD, Battaglin F, Tokunaga R, Naseem M, Zhang W, Philip PA, Marshall JL, Korn WM, et al. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets. Oncogene. PMID 35618879 DOI: 10.1038/s41388-022-02350-6 |
0.01 |
|
| 2022 |
Zhang X, Zhang W, Zhao H. Ultrasound-assisted fabrication of TiCTx MXene toward enhanced energy storage performance. Ultrasonics Sonochemistry. 86: 106024. PMID 35533433 DOI: 10.1016/j.ultsonch.2022.106024 |
0.01 |
|
| 2022 |
Sun HC, Zhou J, Wang Z, Liu X, Xie Q, Jia W, Zhao M, Bi X, Li G, Bai X, Ji Y, Xu L, Zhu XD, Bai D, Chen Y, ... ... Zhang W, et al. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition). Hepatobiliary Surgery and Nutrition. 11: 227-252. PMID 35464283 DOI: 10.21037/hbsn-21-328 |
0.01 |
|
| 2022 |
Yang R, Zhang W, Lu H, Liu J, Xia Y, Liao S, Li X, Zhang X, Fan X, Wang C. Identification of a Novel 15q21.1 Microdeletion in a Family with Marfan Syndrome. Genetics Research. 2022: 3556302. PMID 35440892 DOI: 10.1155/2022/3556302 |
0.01 |
|
| 2022 |
Zhang W, Bai J, Zhou C, Yu H, Wang L. Preparation and properties of water-based acrylic emulsion-assisted flexible building tiles. Rsc Advances. 12: 5340-5348. PMID 35425560 DOI: 10.1039/d2ra00045h |
0.01 |
|
| 2022 |
Bergeron C, Ballard C, Li Y, Zhang W, Zhong Z, Whang K. A low-shrinkage, hydrophobic, degradation-resistant, antimicrobial dental composite using a fluorinated acrylate and an oxirane. Journal of Applied Biomaterials & Functional Materials. 20: 22808000221087337. PMID 35315298 DOI: 10.1177/22808000221087337 |
0.01 |
|
| 2022 |
Sun R, Zhang L, Yang Z, Zhou K, Tang H, Zhao W, Wang N, Yu X, Huang Y, Xie H, Zheng S, Zhang W. Liver transplantation for Hepatocellular Carcinoma: A prognostic model incorporating pretransplant inflammatory cytokines. Cytokine. 153: 155847. PMID 35303693 DOI: 10.1016/j.cyto.2022.155847 |
0.01 |
|
| 2022 |
Zhou Y, Petrovic J, Zhao J, Zhang W, Bigdeli A, Zhang Z, Berger SL, Pear WS, Faryabi RB. EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells. Molecular Cell. PMID 35182476 DOI: 10.1016/j.molcel.2022.01.015 |
0.01 |
|
| 2022 |
Zhang L, Yang Z, Zhang S, Zhou K, Zhang W, Ling S, Sun R, Tang H, Wen X, Feng X, Song P, Xu X, Xie H, Zheng S. Polyploidy Spectrum Correlates with Immunophenotype and Shapes Hepatocellular Carcinoma Recurrence Following Liver Transplantation. Journal of Inflammation Research. 15: 217-233. PMID 35046696 DOI: 10.2147/JIR.S345681 |
0.01 |
|
| 2021 |
Zhang W, Song XL. Occurrence of leaf spot caused by on pygmy date plam () in China. Plant Disease. PMID 34941371 DOI: 10.1094/PDIS-10-21-2190-PDN |
0.01 |
|
| 2021 |
Zhang J, Liu L, Xu T, Zhang W, Zhao C, Li S, Li J, Rao N, Le TD. Exploring cell-specific miRNA regulation with single-cell miRNA-mRNA co-sequencing data. Bmc Bioinformatics. 22: 578. PMID 34856921 DOI: 10.1186/s12859-021-04498-6 |
0.01 |
|
| 2021 |
Li C, Zhang K, Zhang M, Zhang W, Zhao W. Phosphination of Phenol Derivatives and Applications to Divergent Synthesis of Phosphine Ligands. Organic Letters. 23: 8766-8771. PMID 34738819 DOI: 10.1021/acs.orglett.1c03227 |
0.01 |
|
| 2021 |
Arai H, Elliott A, Millstein J, Xiu J, Ou FS, Innocenti F, Wang J, Battaglin F, Jayachandran P, Kawanishi N, Soni S, Zhang W, Sohal D, Goldberg RM, Hall MJ, et al. Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer. Oncogene. PMID 34728807 DOI: 10.1038/s41388-021-02074-z |
0.01 |
|
| 2021 |
Liang D, Tan Q, Jiang W, Zhang W, Wang D, Gong J, Li X, Li L, Zhang Z, Liu Y. Spectrum-continuous narrowband filter with an enhanced flat-top passband and sharp roll-off performance. Optics Letters. 46: 5397-5400. PMID 34724485 DOI: 10.1364/OL.438370 |
0.01 |
|
| 2021 |
Zhang W, Shu X, Huan L, Cheng B, Huo H. Enantioselective β-C(sp)-H arylation of amides synergistic nickel and photoredox catalysis. Organic & Biomolecular Chemistry. PMID 34708852 DOI: 10.1039/d1ob01774h |
0.01 |
|
| 2021 |
Zhang W, Ding ML, Zhang JN, Qiu JR, Shen YH, Ding XY, Deng LF, Zhang WB, Zhu J. Author Correction: mTORC1 Maintains the Tumorigenicity of SSEA-4 High-Grade Osteosarcoma. Scientific Reports. 11: 21434. PMID 34707225 DOI: 10.1038/s41598-021-00930-2 |
0.01 |
|
| 2021 |
Puccini A, Seeber A, Xiu J, Goldberg RM, Soldato D, Grothey A, Shields AF, Salem ME, Battaglin F, Berger MD, El-Deiry WS, Tokunaga R, Naseem M, Zhang W, Arora SP, et al. Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients. Npj Precision Oncology. 5: 95. PMID 34707195 DOI: 10.1038/s41698-021-00230-y |
0.01 |
|
| 2021 |
Arai H, Xiao Y, Millstein J, Wang J, Battaglin F, Kawanishi N, Jayachandran P, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Parikh AR, Lenz HJ. Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer. British Journal of Cancer. PMID 34689170 DOI: 10.1038/s41416-021-01592-7 |
0.01 |
|
| 2021 |
Zhang W, Wang Z, Zhang M, Lin J, Chen W, Hu Y, Li S. Flow Direction-Dependent Elastic Instability in a Symmetry-Breaking Microchannel. Micromachines. 12. PMID 34683190 DOI: 10.3390/mi12101139 |
0.01 |
|
| 2021 |
Kozuka M, Battaglin F, Jayachandran P, Wang J, Arai H, Soni S, Zhang W, Hirai M, Matsusaka S, Lenz HJ. Clinical Significance of Circulating Tumor Cell Induced Epithelial-Mesenchymal Transition in Patients with Metastatic Colorectal Cancer by Single-Cell RNA-Sequencing. Cancers. 13. PMID 34638346 DOI: 10.3390/cancers13194862 |
0.01 |
|
| 2021 |
Guo HZ, Guo ZH, Yu SH, Niu LT, Qiang WT, Huang MM, Tian YY, Chen J, Yang H, Weng XQ, Zhang Y, Zhang W, Hu SY, Shi J, Zhu J. Leukemic progenitor cells enable immunosuppression and post-chemotherapy relapse via IL-36-inflammatory monocyte axis. Science Advances. 7: eabg4167. PMID 34623912 DOI: 10.1126/sciadv.abg4167 |
0.01 |
|
| 2021 |
Fang YX, Li JL, Li XF, Chen MZ, Lin JY, Huang JF, Tang YT, Li JH, Song XL, Zhang W. Causes a Basal Stem and Root Rot of Patchouli () in China. Plant Disease. PMID 34491097 DOI: 10.1094/PDIS-06-21-1300-PDN |
0.01 |
|
| 2021 |
Tian A, Zhong Z, Li Y, Zhang W, Savignano R. Biomechanical Role of Trabecular Microstructure on Peri-implant Strain Based on Micro-CT Finite Element Modeling of Aging Mice. The International Journal of Oral & Maxillofacial Implants. 36: 715-722. PMID 34411210 DOI: 10.11607/jomi.8611 |
0.01 |
|
| 2021 |
Feng Y, He PY, Kong WD, Cen WJ, Wang PL, Liu C, Zhang W, Li SS, Jiang JW. Apoptosis-promoting properties of miR-3074-5p in MC3T3-E1 cells under iron overload conditions. Cellular & Molecular Biology Letters. 26: 37. PMID 34399682 DOI: 10.1186/s11658-021-00281-w |
0.01 |
|
| 2021 |
Zhang J, Liu L, Xu T, Zhang W, Li J, Rao N, Le TD. Time to infer miRNA sponge modules. Wiley Interdisciplinary Reviews. Rna. e1686. PMID 34342388 DOI: 10.1002/wrna.1686 |
0.01 |
|
| 2021 |
Dong Y, Lu J, Wang T, Huang Z, Chen X, Ren Z, Hong L, Wang H, Yang D, Xie H, Zhang W. Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota. Frontiers in Microbiology. 12: 649091. PMID 34276585 DOI: 10.3389/fmicb.2021.649091 |
0.01 |
|
| 2021 |
Zhang W, Li H, Cui L, Li H, Zhang X, Fang S, Zhang Q. Research progress and development trend of surgical robot and surgical instrument arm. The International Journal of Medical Robotics + Computer Assisted Surgery : Mrcas. e2309. PMID 34270175 DOI: 10.1002/rcs.2309 |
0.01 |
|
| 2021 |
Lu J, Qian J, Xu Z, Yin S, Zhou L, Zheng S, Zhang W. Emerging Roles of Liquid-Liquid Phase Separation in Cancer: From Protein Aggregation to Immune-Associated Signaling. Frontiers in Cell and Developmental Biology. 9: 631486. PMID 34235141 DOI: 10.3389/fcell.2021.631486 |
0.01 |
|
| 2021 |
Wang J, Xiu J, Baca Y, Battaglin F, Arai H, Kawanishi N, Soni S, Zhang W, Millstein J, Salhia B, Goldberg RM, Philip PA, Seeber A, Hwang JJ, Shields AF, et al. Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer. Oncogene. PMID 34163031 DOI: 10.1038/s41388-021-01840-3 |
0.01 |
|
| 2021 |
Naseem M, Cao S, Yang D, Millstein J, Puccini A, Loupakis F, Stintzing S, Cremolini C, Tokunaga R, Battaglin F, Soni S, Berger MD, Barzi A, Zhang W, Falcone A, et al. Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients. Scientific Reports. 11: 12191. PMID 34108518 DOI: 10.1038/s41598-021-91330-z |
0.01 |
|
| 2021 |
He S, Zhang W, Li X, Wang J, Chen X, Chen Y, Lai R. Oral squamous cell carcinoma (OSCC)-derived exosomal MiR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation. Bioengineered. 12: 2164-2174. PMID 34098850 DOI: 10.1080/21655979.2021.1932222 |
0.01 |
|
| 2021 |
Zhang M, Han S, Xuan ZY, Fang X, Liu X, Zhang W, Chen HJ. Study of Microwave-Induced Ag Nanowire Welding for Soft Electrode Conductivity Enhancement. Micromachines. 12. PMID 34071895 DOI: 10.3390/mi12060618 |
0.01 |
|
| 2021 |
Suprono MS, Won J, Savignano R, Zhong Z, Ahmed A, Roque-Torres G, Zhang W, Oyoyo U, Richardson P, Caruso J, Handysides R, Li Y. A clinical investigation of dental evacuation systems in reducing aerosols. Journal of the American Dental Association (1939). 152: 455-462. PMID 34044977 DOI: 10.1016/j.adaj.2021.02.013 |
0.01 |
|
| 2021 |
Fang X, Zhang W, Li J, Lin C, Chen Z, Zhang M, Huang S, Lu D, Wan M, Qiu X. Signal processing assisted Vernier effect in a single interferometer for sensitivity magnification. Optics Express. 29: 11570-11581. PMID 33984934 DOI: 10.1364/OE.418783 |
0.01 |
|
| 2021 |
Arai H, Millstein J, Loupakis F, Stintzing S, Wang J, Battaglin F, Kawanishi N, Jayachandran P, Soni S, Zhang W, Mumenthaler SM, Cremolini C, Heinemann V, Falcone A, Lenz HJ. Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancer. European Journal of Cancer (Oxford, England : 1990). 150: 133-142. PMID 33901792 DOI: 10.1016/j.ejca.2021.03.048 |
0.01 |
|
| 2021 |
Suenaga M, Zhang WU, Mashima T, Schirripa M, Cao S, Okazaki S, Berger MD, Miyamoto Y, Barzi A, Yamaguchi T, Lenz HJ. Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients. Cancer Genomics & Proteomics. 18: 317-324. PMID 33893084 DOI: 10.21873/cgp.20262 |
0.01 |
|
| 2021 |
Qu L, Zhang W, Li J, Liu P. The miR-146b-5p promotes Ewing's sarcoma cells progression via suppressing the expression of BTG2. Science Progress. 104: 368504211002043. PMID 33844600 DOI: 10.1177/00368504211002043 |
0.01 |
|
| 2021 |
Zhang J, Liu L, Xu T, Zhang W, Zhao C, Li S, Li J, Rao N, Le TD. miRSM: an R package to infer and analyse miRNA sponge modules in heterogeneous data. Rna Biology. 1-13. PMID 33822666 DOI: 10.1080/15476286.2021.1905341 |
0.01 |
|
| 2021 |
Zhang W, Zhang B, Fang X, Cheng K, Chen W, Wang Z, Hong D, Zhang M. Microfluid-based soft metasurface for tunable optical activity in THz wave. Optics Express. 29: 8786-8795. PMID 33820320 DOI: 10.1364/OE.420660 |
0.01 |
|
| 2021 |
Arai H, Cao S, Battaglin F, Wang J, Kawanishi N, Tokunaga R, Loupakis F, Stintzing S, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Cremolini C, Heinemann V, et al. RNA-binding protein polymorphisms as novel biomarkers to predict outcomes of metastatic colorectal cancer: A meta-analysis from TRIBE, FIRE-3 and MAVERICC. Molecular Cancer Therapeutics. PMID 33785650 DOI: 10.1158/1535-7163.MCT-20-0649 |
0.01 |
|
| 2021 |
Arai H, Elliott A, Xiu J, Wang J, Battaglin F, Kawanishi N, Soni S, Zhang W, Millstein J, Sohal D, Goldberg RM, Hall MJ, Scott AJ, Khushman M, Hwang JJ, et al. The landscape of alterations in DNA damage response pathways in colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33766816 DOI: 10.1158/1078-0432.CCR-20-3635 |
0.01 |
|
| 2021 |
Zhang W, Lin Y, Gao Y, Guo Z, Li X, Hu Y, Dong P, Zhang Q, Fang X, Zhang M. Numerical and Experimental Investigation on the Optical Manipulation from an Axicon Lensed Fiber. Micromachines. 12. PMID 33673323 DOI: 10.3390/mi12020187 |
0.01 |
|
| 2021 |
Siddiqui SS, Vaill M, Do R, Khan N, Verhagen AL, Zhang W, Lenz HJ, Johnson-Pais TL, Leach RJ, Fraser G, Wang C, Feng GS, Varki N, Varki A. Human-specific polymorphic pseudogenization of protects against advanced cancer progression. Faseb Bioadvances. 3: 69-82. PMID 33615152 DOI: 10.1096/fba.2020-00092 |
0.01 |
|
| 2021 |
Suenaga M, Schirripa M, Cao S, Zhang W, Cremolini C, Lonardi S, Okazaki S, Berger MD, Miyamoto Y, Soni S, Barzi A, Yamaguchi T, Loupakis F, Falcone A, Lenz HJ. Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer. The Pharmacogenomics Journal. PMID 33542444 DOI: 10.1038/s41397-021-00207-x |
0.01 |
|
| 2021 |
Zhang X, Feng S, Wang Q, Huang H, Chen R, Xie Q, Zhang W, Wang A, Zhang S, Wang L, Yao M, Ling Q. Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages. Journal of Cellular and Molecular Medicine. PMID 33452856 DOI: 10.1111/jcmm.16281 |
0.01 |
|
| 2021 |
Zhang W, Ji Y, Shen N, Jia Q, Chang W. Study of the photodegradation of 2-chlorobenzoic acid by TiO and the effects of eutrophicated water on the reaction. Saudi Journal of Biological Sciences. 28: 163-169. PMID 33424293 DOI: 10.1016/j.sjbs.2020.09.029 |
0.01 |
|
| 2021 |
Kawanishi N, Baca Y, Xiu J, Arai H, Wang J, Battaglin F, Soni S, Zhang W, Shields AF, Goldberg RM, Weinberg BA, Lou E, Sohal D, Hall MJ, Seeber A, et al. Molecular characterization of pancreatic cancers as seen in the SLUG gene revealing cancer progression. Journal of Clinical Oncology. 39: 433-433. DOI: 10.1200/JCO.2021.39.3_SUPPL.433 |
0.01 |
|
| 2021 |
Wang J, Millstein J, Loupakis F, Stintzing S, Arai H, Battaglin F, Kawanishi N, Soni S, Zhang W, Mancao C, Cremolini C, Heinemann V, Falcone A, Lenz H. Genetic variants involved in the lipid metabolism pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and MAVERICC trials. Journal of Clinical Oncology. 39: 118-118. DOI: 10.1200/JCO.2021.39.3_SUPPL.118 |
0.01 |
|
| 2021 |
Jayachandran P, Xiu J, Soni S, Goldberg RM, Weinberg BA, Lou E, Hall MJ, Khushman MM, Sohal D, Battaglin F, Arai H, Zhang W, Wang J, Korn WM, Millstein J, et al. GDF15 expression in metastatic colorectal cancer. Journal of Clinical Oncology. 39: 116-116. DOI: 10.1200/JCO.2021.39.3_SUPPL.116 |
0.01 |
|
| 2021 |
Wang J, Millstein J, Loupakis F, Stintzing S, Arai H, Battaglin F, Kawanishi N, Jayachandran P, Soni S, Zhang W, Mancao C, Cremolini C, Heinemann V, Falcone A, Lenz H. The role of PP2A variants to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and TRIBE trials. Journal of Clinical Oncology. 39: 3581-3581. DOI: 10.1200/JCO.2021.39.15_SUPPL.3581 |
0.01 |
|
| 2021 |
Battaglin F, Xiu J, Zeng J, Baca Y, Jayachandran P, Kawanishi N, Arai H, Deshpande K, Goldberg RM, Lockhart AC, Hwang JJ, Seeber A, Zhang W, Mumenthaler SM, Shields AF, et al. Comprehensive characterization of neurotransmitters and neuronal signaling (NT) pathway alterations in colorectal cancer (CRC). Journal of Clinical Oncology. 39: 3537-3537. DOI: 10.1200/JCO.2021.39.15_SUPPL.3537 |
0.01 |
|
| 2021 |
Wang J, Xiao Y, Loupakis F, Stintzing S, Arai H, Battaglin F, Kawanishi N, Jayachandran P, Soni S, Zhang W, Mancao C, Cremolini C, Heinemann V, Falcone A, Millstein J, et al. Genetic variants involved in the cGAS-STING pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and TRIBE trials. Journal of Clinical Oncology. 39: 3535-3535. DOI: 10.1200/JCO.2021.39.15_SUPPL.3535 |
0.01 |
|
| 2021 |
Jayachandran P, Baca Y, Xiu J, Zhang J, Battaglin F, Arai H, Goldberg RM, Weinberg BA, Lou E, Hall MJ, Khushman MM, Sohal D, Soni S, Wang J, Zhang W, et al. Globo H expression in metastatic colorectal cancer (CRC). Journal of Clinical Oncology. 39: 3527-3527. DOI: 10.1200/JCO.2021.39.15_SUPPL.3527 |
0.01 |
|
| 2021 |
Kawanishi N, Baca Y, Xiu J, Arai H, Battaglin F, Jayachandran P, Soni S, Zhang W, Philip PA, Sohal D, Khushman M, Weinberg BA, Hall MJ, Park DJ, Shields AF, et al. Association of high gene expression levels of ARF6 with the immune microenvironment and prediction of poor outcomes. Journal of Clinical Oncology. 39: 3092-3092. DOI: 10.1200/JCO.2021.39.15_SUPPL.3092 |
0.01 |
|
| 2021 |
Battaglin F, Amzaleg Y, Kozuka M, Jayachandran P, Matsusaka S, Hirai M, Wang J, Arai H, Kawanishi N, Soni S, Zhang W, Yu M, Lenz H. Single cell RNA-sequence analysis to identify transcriptomic differences associated with treatment outcome and ethnicity in circulating tumor cells (CTCs) from patients (pts) with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 39: 3041-3041. DOI: 10.1200/JCO.2021.39.15_SUPPL.3041 |
0.01 |
|
| 2020 |
Zhang W, Pear WS. MYC degradation via AURKB inhibition: a new brake in the path to T-ALL. Blood Science (Baltimore, Md.). 2: 68-69. PMID 35402818 DOI: 10.1097/BS9.0000000000000046 |
0.01 |
|
| 2020 |
Zhang W, Li H, Yu WW, Elezzabi AY. Transparent inorganic multicolour displays enabled by zinc-based electrochromic devices. Light, Science & Applications. 9: 121. PMID 34257269 DOI: 10.1038/s41377-020-00366-9 |
0.01 |
|
| 2020 |
Arai H, Xiao Y, Loupakis F, Kawanishi N, Wang J, Battaglin F, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, Cremolini C, Falcone A, et al. Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer. Journal For Immunotherapy of Cancer. 8. PMID 33172883 DOI: 10.1136/jitc-2020-001714 |
0.01 |
|
| 2020 |
Zhang W, Niu XL, Yang JY. First report of postharvest fruit rot on passion fruit () caused by in Mainland China. Plant Disease. PMID 33147123 DOI: 10.1094/PDIS-06-20-1346-PDN |
0.01 |
|
| 2020 |
Xie J, Song X, Zhang W, Dong Q, Wang Y, Li F, Wan C. A novel approach with dual-sampling convolutional neural network for ultrasound image classification of breast tumors. Physics in Medicine and Biology. PMID 33120380 DOI: 10.1088/1361-6560/abc5c7 |
0.01 |
|
| 2020 |
Tokunaga R, Xiu J, Goldberg RM, Philip PA, Seeber A, Battaglin F, Arai H, Lo JH, Naseem M, Puccini A, Berger MD, Soni S, Zhang W, Chen S, Hwang JJ, et al. The impact of ARID1A mutation on molecular characteristics in colorectal cancer. European Journal of Cancer (Oxford, England : 1990). 140: 119-129. PMID 33080474 DOI: 10.1016/j.ejca.2020.09.006 |
0.01 |
|
| 2020 |
Zhu HK, Zhuang L, Chen CZ, Ye ZD, Wang ZY, Zhang W, Cao GH, Zheng SS. Safety and efficacy of an integrated endovascular treatment strategy for early hepatic artery occlusion after liver transplantation. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. PMID 33071179 DOI: 10.1016/j.hbpd.2020.09.014 |
0.01 |
|
| 2020 |
Volz NB, Hanna DL, Stintzing S, Zhang W, Yang D, Cao S, Ning Y, Matsusaka S, Sunakawa Y, Berger MD, Cremolini C, Loupakis F, Falcone A, Lenz HJ. Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients. Cancers. 12. PMID 33065994 DOI: 10.3390/cancers12102947 |
0.01 |
|
| 2020 |
Arai H, Baca Y, Battaglin F, Kawanishi N, Wang J, Soni S, Zhang W, Millstein J, Johnston C, Goldberg RM, Philip PA, Seeber A, Xiu J, Hwang JJ, Shields AF, et al. Molecular characterization of appendiceal goblet cell carcinoid. Molecular Cancer Therapeutics. PMID 33037134 DOI: 10.1158/1535-7163.MCT-20-0318 |
0.01 |
|
| 2020 |
Miyamoto Y, Schirripa M, Suenaga M, Cao S, Zhang W, Okazaki S, Berger MD, Matsusaka S, Yang D, Ning Y, Baba H, Loupakis F, Lonardi S, Pietrantonio F, Borelli B, et al. A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer. Plos One. 15: e0239439. PMID 32970737 DOI: 10.1371/journal.pone.0239439 |
0.01 |
|
| 2020 |
Li H, Zhang W, Elezzabi AY. Transparent Zinc-Mesh Electrodes for Solar-Charging Electrochromic Windows. Advanced Materials (Deerfield Beach, Fla.). e2003574. PMID 32954551 DOI: 10.1002/Adma.202003574 |
0.01 |
|
| 2020 |
Zhang W, Wu Y, Chen H, Yu D, Zhao J, Chen J. Neuroprotective Effects of SOX5 against Ischemic Stroke by Regulating VEGF/PI3K/AKT pathway. Gene. 145148. PMID 32949698 DOI: 10.1016/j.gene.2020.145148 |
0.01 |
|
| 2020 |
Puccini A, Poorman K, Salem ME, Soldato D, Seeber A, Goldberg RM, Shields AF, Xiu J, Battaglin F, Berger MD, Tokunaga R, Naseem M, Barzi A, Iqbal S, Zhang W, et al. Comprehensive genomic profiling of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32883742 DOI: 10.1158/1078-0432.Ccr-20-1804 |
0.01 |
|
| 2020 |
Zhao JB, Xue JF, Zhang WZ, Ren YL, Yan DM. Long Noncoding RNA FGD5-AS1 Promotes Glioma Cell Proliferation, Migration and Invasion by Regulating wnt/β-Catenin Pathway. Cancer Management and Research. 12: 6187-6193. PMID 32801867 DOI: 10.2147/CMAR.S250284 |
0.01 |
|
| 2020 |
Lu J, Qian J, Yin S, Zhou L, Zheng S, Zhang W. Mechanisms of RNA N-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology. Frontiers in Oncology. 10: 1105. PMID 32733807 DOI: 10.3389/fonc.2020.01105 |
0.01 |
|
| 2020 |
Suenaga M, Cao S, Zhang W, Matsusaka S, Okazaki S, Berger MD, Miyamoto Y, Schirripa M, Barzi A, Yamamoto N, Yamaguchi T, Lenz HJ. Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer. Pharmacogenetics and Genomics. PMID 32732498 DOI: 10.1097/FPC.0000000000000416 |
0.01 |
|
| 2020 |
Li Z, Li L, Zhang W, Li M. [Culture and identification of dendritic cells derived from bone marrow of DA rats]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology. 36: 577-582. PMID 32727640 |
0.01 |
|
| 2020 |
Li D, Zhang H, Chang M, Shen K, Zhang N, Zhu K, Zhou Z, Zhang W, Wang Q, Liu X, Zhang W. Neonicotinoid insecticide and their metabolite residues in fruit juices: Implications for dietary intake in China. Chemosphere. 261: 127682. PMID 32711240 DOI: 10.1016/j.chemosphere.2020.127682 |
0.01 |
|
| 2020 |
Lu J, Wei S, Lou J, Yin S, Zhou L, Zhang W, Zheng S. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 26: e925733. PMID 32706768 DOI: 10.12659/MSM.925733 |
0.01 |
|
| 2020 |
Zhang W, Li H, Yu WW, Elezzabi AY. Transparent inorganic multicolour displays enabled by zinc-based electrochromic devices. Light, Science & Applications. 9: 121. PMID 32695318 DOI: 10.1038/S41377-020-00366-9 |
0.01 |
|
| 2020 |
Wei S, Lu J, Lou J, Shi C, Mo S, Shao Y, Ni J, Zhang W, Cheng X. Gastric Cancer Tumor Microenvironment Characterization Reveals Stromal-Related Gene Signatures Associated With Macrophage Infiltration. Frontiers in Genetics. 11: 663. PMID 32695142 DOI: 10.3389/fgene.2020.00663 |
0.01 |
|
| 2020 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Cremolini C, Murgioni S, Lonardi S, Ning Y, Okazaki S, Berger MD, Miyamoto Y, Barzi A, Loupakis F, Falcone A, et al. Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE Trial. Cancers. 12. PMID 32629861 DOI: 10.3390/cancers12071742 |
0.01 |
|
| 2020 |
Zhan QF, Ling SB, Deng YN, Shan QN, Ye QW, Xu SJ, Jiang GJ, Lu D, Wei XY, Zhuang L, Zhang W, Shen T, Cen BN, Xie HY, Liu JM, et al. Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. PMID 32622826 DOI: 10.1016/j.hbpd.2020.06.011 |
0.01 |
|
| 2020 |
Barat A, Smeets D, Moran B, Zhang W, Cao S, Das S, Klinger R, Betge J, Murphy V, Bacon O, Kay EW, Van Grieken NCT, Verheul HMW, Gaiser T, Schulte N, et al. Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer. Scientific Reports. 10: 9778. PMID 32555399 DOI: 10.1038/S41598-020-65869-2 |
0.01 |
|
| 2020 |
Zhang W, Wang Y, Zhao H. Continuous Operation on Synthesis and Surface Modification of Rutile Nanoparticles in Designed Microfluidic Reactors. Acs Omega. 5: 12816-12824. PMID 32548465 DOI: 10.1021/acsomega.0c00445 |
0.01 |
|
| 2020 |
Jiang G, Zhang W, Wang T, Ding S, Shi X, Zhang S, Shi W, Liu A, Zheng S. Characteristics of genomic alterations in Chinese cholangiocarcinoma patients. Japanese Journal of Clinical Oncology. PMID 32533190 DOI: 10.1093/jjco/hyaa088 |
0.01 |
|
| 2020 |
Zhang W, Yang W, Zhao W. Lewis acid-promoted site-selective cyanation of phenols. Organic & Biomolecular Chemistry. PMID 32515758 DOI: 10.1039/d0ob00737d |
0.01 |
|
| 2020 |
Wu SF, Xia L, Shi XD, Dai YJ, Zhang WN, Zhao JM, Zhang W, Weng XQ, Lu J, Le HY, Tao SC, Zhu J, Chen Z, Wang YY, Chen S. RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation. Proceedings of the National Academy of Sciences of the United States of America. PMID 32513696 DOI: 10.1073/pnas.1918596117 |
0.01 |
|
| 2020 |
Zhang W, Yang W, Zhao W. Lewis Acid Mediated Electrophilic Cyanation of 2,2'-Biphenols. The Journal of Organic Chemistry. PMID 32512992 DOI: 10.1021/acs.joc.0c00458 |
0.01 |
|
| 2020 |
Zhang J, Xu T, Liu L, Zhang W, Zhao C, Li S, Li J, Rao N, Le TD. LMSM: A modular approach for identifying lncRNA related miRNA sponge modules in breast cancer. Plos Computational Biology. 16: e1007851. PMID 32324747 DOI: 10.1371/journal.pcbi.1007851 |
0.01 |
|
| 2020 |
Berger MD, Ning Y, Stintzing S, Heinemann V, Cao S, Zhang W, Yang D, Miyamoto Y, Suenaga M, Schirripa M, Hanna DL, Soni S, Puccini A, Tokunaga R, Naseem M, et al. A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials. European Journal of Cancer (Oxford, England : 1990). 131: 89-97. PMID 32305727 DOI: 10.1016/j.ejca.2020.02.048 |
0.01 |
|
| 2020 |
Zhang W, Damm U, Crous PW, Groenewald JZ, Niu X, Lin J, Li Y. Anthracnose Disease of Carpetgrass () Caused by sp. nov. Plant Disease. PDIS10192183RE. PMID 32290774 DOI: 10.1094/PDIS-10-19-2183-RE |
0.01 |
|
| 2020 |
Hassani H, Chen JW, Zhang W, Hamra W. Comparison of Microbial Activity Among Infants With or Without Using Presurgical Nasoalveolar Molding Appliance. The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association. 1055665620908150. PMID 32253929 DOI: 10.1177/1055665620908150 |
0.01 |
|
| 2020 |
Stremitzer S, Vermeulen P, Graver S, Kockx M, Dirix L, Yang D, Zhang W, Stift J, Wrba F, Gruenberger T, Lenz HJ, Scherer SJ. Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases. British Journal of Cancer. PMID 32205863 DOI: 10.1038/S41416-020-0812-Z |
0.01 |
|
| 2020 |
Zhang WY, Hallock GG. Gillies and Dunedin: The birthplace of modern plastic surgery. Journal of Plastic, Reconstructive & Aesthetic Surgery : Jpras. PMID 32201324 DOI: 10.1016/j.bjps.2020.02.011 |
0.01 |
|
| 2020 |
Zhang W, Tan Q, Li X, Wang D. Photonic generation of background-free frequency-doubled phase-coded microwave pulses with immunity to periodic power fading. Optics Letters. 45: 1407-1410. PMID 32163978 DOI: 10.1364/OL.386138 |
0.01 |
|
| 2020 |
Liu S, Cai X, Xue W, Ma D, Zhang W. Chitosan derivatives co-delivering nitric oxide and methicillin for the effective therapy to the methicillin-resistant S. aureus infection. Carbohydrate Polymers. 234: 115928. PMID 32070544 DOI: 10.1016/j.carbpol.2020.115928 |
0.01 |
|
| 2020 |
Zhang H, Quan Q, Zhang M, Zhang N, Zhang W, Zhan M, Xu W, Lu L, Fan J, Wang Q. Occurrence of bisphenol A and its alternatives in paired urine and indoor dust from Chinese university students: Implications for human exposure. Chemosphere. 247: 125987. PMID 32069736 DOI: 10.1016/j.chemosphere.2020.125987 |
0.01 |
|
| 2020 |
Ni J, Zhong Z, Zhang W, Liu B, Shu R, Li Y. Fluoride resistance in fibroblasts is conferred via reduced susceptibility to oxidative stress and apoptosis. Febs Open Bio. PMID 31930721 DOI: 10.1002/2211-5463.12786 |
0.01 |
|
| 2020 |
Battaglin F, Xiu J, Baca Y, Shields AF, Goldberg RM, Seeber A, Habib D, Soni S, Puccini A, Tokunaga R, Arai H, Wang J, Berger MD, Astsaturov IA, Lockhart AC, ... Zhang W, et al. Comprehensive molecular profiling of IDH1/2 mutant biliary cancers (BC). Journal of Clinical Oncology. 38: 479-479. DOI: 10.1200/Jco.2020.38.4_Suppl.479 |
0.01 |
|
| 2020 |
Wang J, Xiu J, Baca Y, Goldberg RM, Philip PA, Seeber A, Battaglin F, Arai H, Soni S, Tokunaga R, Zhang W, Hwang JJ, Shields AF, Marshall J, Astsaturov IA, et al. Molecular landscape of gastric cancer (GC) harboring mutations of histone methyltransferases. Journal of Clinical Oncology. 38: 418-418. DOI: 10.1200/Jco.2020.38.4_Suppl.418 |
0.01 |
|
| 2020 |
Naseem M, Cao S, Stintzing S, Battaglin F, Tokunaga R, Puccini A, Berger MD, Soni S, Zhang W, Barzi A, Heinemann V, Lenz H. Variation in genetic polymorphisms and gene expression of HLA-E to predict outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI/cetuximab: Data from the phase III FIRE-3 trial. Journal of Clinical Oncology. 38: 245-245. DOI: 10.1200/jco.2020.38.4_suppl.245 |
0.01 |
|
| 2020 |
Wang J, Xiao Y, Loupakis F, Stintzing S, Arai H, Battaglin F, Soni S, Zhang W, Mancao C, Cremolini C, Heinemann V, Falcone A, Millstein J, Lenz H. Genetic variants involved in bromodomain-containing protein 4 (BRD4) regulating pathway to predict outcomes in patients with metastatic colorectal cancer: Results from FIRE3 and MAVERICC trials. Journal of Clinical Oncology. 38: 232-232. DOI: 10.1200/jco.2020.38.4_suppl.232 |
0.01 |
|
| 2020 |
Arai H, Baca Y, Johnston C, Goldberg RM, Philip PA, Seeber A, Battaglin F, Xiu J, Wang J, Soni S, Zhang W, Hwang JJ, Shields AF, Marshall J, Korn WM, et al. Molecular characterization of appendiceal goblet cell carcinoid. Journal of Clinical Oncology. 38: 231-231. DOI: 10.1200/jco.2020.38.4_suppl.231 |
0.01 |
|
| 2020 |
Berger MD, Zlobec I, Cao S, Miyamoto Y, Suenaga M, Soni S, Puccini A, Tokunaga R, Naseem M, Battaglin F, Zhang W, Lugli A, Lenz H. Polymorphisms of genes encoding for regulatory proteins in the coagulation cascade to predict outcome for stage II and III colon cancer. Journal of Clinical Oncology. 38: 227-227. DOI: 10.1200/jco.2020.38.4_suppl.227 |
0.01 |
|
| 2020 |
Suenaga M, Zhang W, Mashima T, Schirripa M, Cao S, Okazaki S, Berger MD, Miyamoto Y, Barzi A, Lenz H. Gene polymorphisms of CCL3, CCL4, CCL5, and CCR5 network in metastatic colorectal cancer patients treated with regorafenib. Journal of Clinical Oncology. 38: 199-199. DOI: 10.1200/jco.2020.38.4_suppl.199 |
0.01 |
|
| 2020 |
Battaglin F, Xiao Y, Millstein J, Seeber A, Arai H, Wang J, Puccini A, Tokunaga R, Naseem M, Soni S, Berger MD, Barzi A, Zhang W, Stintzing S, Heinemann V, et al. Genetic variants in R-Spondin/RNF43 complex and gene expression levels to predict efficacy of cetuximab (cet) in patients (pts) with metastatic colorectal cancer (mCRC): Data from the FIRE-3 phase III trial. Journal of Clinical Oncology. 38: 190-190. DOI: 10.1200/jco.2020.38.4_suppl.190 |
0.01 |
|
| 2020 |
Arai H, Xiao Y, Loupakis F, Stintzing S, Wang J, Battaglin F, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, Cremolini C, Heinemann V, et al. Genetic variants in immunogenic cell death (ICD) relating genes to predict outcome in metastatic colorectal cancer (mCRC): Data from FIRE-3, TRIBE and MAVERICC trials. Journal of Clinical Oncology. 38: 187-187. DOI: 10.1200/Jco.2020.38.4_Suppl.187 |
0.01 |
|
| 2020 |
Lenz A, Zhang W, Xiao Y, Millstein J, Soni S, Arai H, Wang J, Parikh AR, Mancao C, Stintzing S, Heinemann V, Battaglin F. CCR5 Δ32 mutation and gene expression to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and MAVERICC phase III trials. Journal of Clinical Oncology. 38: 170-170. DOI: 10.1200/jco.2020.38.4_suppl.170 |
0.01 |
|
| 2020 |
Battaglin F, Xiu J, Baca Y, Zeng J, Shields AF, Goldberg RM, Seeber A, Habib D, Puccini A, Tokunaga R, Arai H, Wang J, Berger MD, Astsaturov IA, Lockhart AC, ... Zhang W, et al. Comprehensive gene expression analysis of IDH1/2 mutant biliary cancers (BC). Journal of Clinical Oncology. 38: 4598-4598. DOI: 10.1200/Jco.2020.38.15_Suppl.4598 |
0.01 |
|
| 2020 |
Wang J, Xiu J, Shields AF, Grothey A, Weinberg BA, Marshall J, Lou E, Khushman MM, Sohal D, Hall MJ, Battaglin F, Arai H, Soni S, Zhang W, Korn WM, et al. Molecular correlates of PD-L1 expression in patients (pts) with gastroesophageal (GE) cancers. Journal of Clinical Oncology. 38: 4558-4558. DOI: 10.1200/Jco.2020.38.15_Suppl.4558 |
0.01 |
|
| 2020 |
Arai H, Elliott A, Xiu J, Wang J, Battaglin F, Soni S, Zhang W, Sohal D, Goldberg RM, Hall MJ, Scott AJ, Khushman M, Hwang JJ, Lou E, Weinberg BA, et al. Somatic alterations of NF1 in colorectal cancer. Journal of Clinical Oncology. 38: 4066-4066. DOI: 10.1200/Jco.2020.38.15_Suppl.4066 |
0.01 |
|
| 2020 |
Arai H, Elliott A, Wang J, Battaglin F, Soni S, Zhang W, Sohal D, Goldberg RM, Hall MJ, Scott AJ, Khushman M, Hwang JJ, Lou E, Weinberg BA, Marshall J, et al. The landscape of DNA damage response (DDR) pathway in colorectal cancer (CRC). Journal of Clinical Oncology. 38: 4064-4064. DOI: 10.1200/jco.2020.38.15_suppl.4064 |
0.01 |
|
| 2020 |
Wang J, Xiu J, Shields AF, Grothey A, Weinberg BA, Marshall J, Lou E, Khushman MM, Sohal D, Hall MJ, Battaglin F, Arai H, Soni S, Zhang W, Korn WM, et al. Comprehensive molecular analysis of microsatellite-stable (MSS) tumors with high mutational burden in gastrointestinal (GI) cancers. Journal of Clinical Oncology. 38: 3631-3631. DOI: 10.1200/Jco.2020.38.15_Suppl.3631 |
0.01 |
|
| 2020 |
Jayachandran P, Elliott A, Battaglin F, Lou E, Zhang W, Soni S, Arai H, Wang J, Millstein J, Lockhart A, Korn W, Lenz H. 473P PLK1 expression and KRAS mutations in colorectal cancer Annals of Oncology. 31: S442. DOI: 10.1016/j.annonc.2020.08.584 |
0.01 |
|
| 2020 |
Battaglin F, Zhang W, Skubala A, Arai H, Wang J, Soni S, Wang Y, Köchert K, Schulz A, Teufel M, Millstein J, Lenz H. 465P Single nucleotide polymorphism (SNP) analysis identifies potential prognostic and predictive biomarker in patients (pts) with metastatic colorectal cancer (mCRC) treated with regorafenib in the phase III CORRECT trial Annals of Oncology. 31: S439. DOI: 10.1016/j.annonc.2020.08.576 |
0.01 |
|
| 2020 |
Battaglin F, Xiu J, Baca Y, Shields A, Goldberg R, Puccini A, Tokunaga R, Arai H, Wang J, Kawanishi N, Seeber A, Astaturov I, Lockhart A, Zhang W, Marshall J, et al. 1952P Comprehensive profiling of MDM2 amplified gastrointestinal (GI) cancers Annals of Oncology. 31: S1100. DOI: 10.1016/j.annonc.2020.08.1344 |
0.01 |
|
| 2019 |
Wang S, Sun L, Ling N, Zhu C, Chi F, Li W, Hao X, Zhang W, Bian J, Chen L, Wei D. Exploring Soil Factors Determining Composition and Structure of the Bacterial Communities in Saline-Alkali Soils of Songnen Plain. Frontiers in Microbiology. 10: 2902. PMID 32010065 DOI: 10.3389/fmicb.2019.02902 |
0.01 |
|
| 2019 |
Matsusaka S, Hanna DL, Ning Y, Yang D, Cao S, Berger MD, Miyamoto Y, Suenaga M, Dan S, Mashima T, Seimiya H, Zhang W, Lenz HJ. Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib. Cancer Science. PMID 31821662 DOI: 10.1111/Cas.14273 |
0.01 |
|
| 2019 |
Arai H, Battaglin F, Wang J, Lo JH, Soni S, Zhang W, Lenz HJ. Molecular insight of regorafenib treatment for colorectal cancer. Cancer Treatment Reviews. 81: 101912. PMID 31715423 DOI: 10.1016/j.ctrv.2019.101912 |
0.01 |
|
| 2019 |
Ge W, Hu H, Cai W, Xu J, Hu W, Weng X, Qin X, Huang Y, Han W, Hu Y, Yu J, Zhang W, Ye S, Qi L, Huang P, et al. High-risk stage III colon cancer patients identified by a novel 5-gene mutational signature are characterized by up-regulation of IL-23A and gut bacterial translocation of the tumor microenvironment. International Journal of Cancer. PMID 31693169 DOI: 10.1002/ijc.32775 |
0.01 |
|
| 2019 |
Zhao J, Jiang X, Yan L, Lin J, Guo H, Yu S, Ye B, Zhu J, Zhang W. Retinoic acid inducible gene-I slows down cellular senescence through negatively regulating the integrin β3/p38 MAPK pathway. Cell Cycle (Georgetown, Tex.). 1-15. PMID 31595820 DOI: 10.1080/15384101.2019.1677074 |
0.01 |
|
| 2019 |
Millstein J, Battaglin F, Barrett M, Cao S, Zhang W, Stintzing S, Heinemann V, Lenz HJ. Partition: a surjective mapping approach for dimensionality reduction. Bioinformatics (Oxford, England). PMID 31504178 DOI: 10.1093/bioinformatics/btz661 |
0.01 |
|
| 2019 |
Wang F, Li X, Li Z, Zhou S, Zhang W. Copper Salts/TBAB-Catalyzed Chemo- and Regioselective β-C(sp)-H Acyloxylation of Aliphatic Amides. Acs Omega. 4: 331-343. PMID 31459332 DOI: 10.1021/acsomega.8b02430 |
0.01 |
|
| 2019 |
Zhang K, Zhao SH, Wen AJ, Zhang W, Zhai WL, Lin T, Li X. Anti-chromatic dispersion transmission of frequency and bandwidth-doubling dual-chirp microwave waveform. Optics Letters. 44: 4004-4007. PMID 31415533 DOI: 10.1364/OL.44.004004 |
0.01 |
|
| 2019 |
Feng Y, Kong WD, Cen WJ, Zhou XZ, Zhang W, Li QT, Guo HY, Yu JW. Finite element analysis of the effect of power arm locations on tooth movement in extraction space closure with miniscrew anchorage in customized lingual orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics. 156: 210-219. PMID 31375231 DOI: 10.1016/j.ajodo.2018.08.025 |
0.01 |
|
| 2019 |
Zhang W, Zheng Y, Liu H, Zhu X, Gu Y, Lan Y, Tan J, Xu H, Guo R. A non-invasive monitoring of USPIO labeled silk fibroin/hydroxyapatite scaffold loaded DPSCs for dental pulp regeneration. Materials Science & Engineering. C, Materials For Biological Applications. 103: 109736. PMID 31349524 DOI: 10.1016/j.msec.2019.05.021 |
0.01 |
|
| 2019 |
Donner DB, Nakakura EK, Venook AP, Lenz HJ, Zhang W, Hwang J, Bergsland EK, Lin MH, Toriguchi K, Antonia RJ, Warren RS. High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma. Plos One. 14: e0219469. PMID 31291332 DOI: 10.1371/Journal.Pone.0219469 |
0.01 |
|
| 2019 |
Zhang M, Zhang W, Wu Z, Shen Y, Wu H, Cheng J, Zhang H, Li F, Cai W. Modulation of viscoelastic fluid response to external body force. Scientific Reports. 9: 9402. PMID 31253813 DOI: 10.1038/S41598-019-45612-2 |
0.01 |
|
| 2019 |
Lin J, Zhang W, Niu LT, Zhu YM, Weng XQ, Sheng Y, Zhu J, Xu J. TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31235507 DOI: 10.1158/1078-0432.CCR-19-0510 |
0.01 |
|
| 2019 |
Guo HZ, Niu LT, Qiang WT, Chen J, Wang J, Yang H, Zhang W, Zhu J, Yu SH. Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201900099R. PMID 31136196 DOI: 10.1096/fj.201900099R |
0.01 |
|
| 2019 |
Zhang W, Li H, Firby CJ, Al-Hussein M, Elezzabi AY. Oxygen Vacancy Tunable Electrochemical Properties of Electrodeposited Molybdenum Oxide Films. Acs Applied Materials & Interfaces. PMID 31094499 DOI: 10.1021/Acsami.9B04386 |
0.01 |
|
| 2019 |
Shan D, Wen A, Zhai W, Li X, Zhang W, Tu Z. Filter-free image-reject microwave photonic downconverter based on cascaded modulators. Applied Optics. 58: 3432-3437. PMID 31044839 DOI: 10.1364/AO.58.003432 |
0.01 |
|
| 2019 |
Zhang M, Zhang W, Wu Z, Shen Y, Chen Y, Lan C, Li F, Cai W. Comparison of Micro-Mixing in Time Pulsed Newtonian Fluid and Viscoelastic Fluid. Micromachines. 10. PMID 31003548 DOI: 10.3390/mi10040262 |
0.01 |
|
| 2019 |
Xu J, Chen LJ, Yang SS, Sun Y, Wu W, Liu YF, Xu J, Zhuang Y, Zhang W, Weng XQ, Wu J, Wang Y, Wang J, Yan H, Xu WB, et al. Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America. PMID 30988175 DOI: 10.1073/Pnas.1819745116 |
0.01 |
|
| 2019 |
Li Y, Lee S, Stephens J, Zhang W, Suprono M, Mwatha A, Ward M, Mirza F. A Randomized Parallel Study to Assess the Effect of Three Tongue Cleaning Modalities on Oral Malodor. The Journal of Clinical Dentistry. 30: A30-38. PMID 30964972 |
0.01 |
|
| 2019 |
Li G, Wang H, Ma D, Xue W, Zhang W. A star copolymer consisting of a β-cyclodextrin core and poly(amidoamine) dendron arms for co-delivering nitric oxide and triclosan for combined antibacterial effect. Acta Biomaterialia. PMID 30926578 DOI: 10.1016/j.actbio.2019.03.051 |
0.01 |
|
| 2019 |
Tokunaga R, Cao S, Naseem M, Battaglin F, Lo JH, Arai H, Loupakis F, Stintzing S, Puccini A, Berger MD, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, et al. AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: a meta-analysis using TRIBE, MAVERICC, and FIRE3. International Journal of Cancer. PMID 30856283 DOI: 10.1002/Ijc.32261 |
0.01 |
|
| 2019 |
Puccini A, Loupakis F, Stintzing S, Cao S, Battaglin F, Togunaka R, Naseem M, Berger MD, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, et al. Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3. European Journal of Cancer (Oxford, England : 1990). 111: 138-147. PMID 30852420 DOI: 10.1016/J.Ejca.2019.01.105 |
0.01 |
|
| 2019 |
Tokunaga R, Xiu J, Johnston C, Goldberg RM, Philip PA, Seeber A, Naseem M, Lo JH, Arai H, Battaglin F, Puccini A, Berger MD, Soni S, Zhang W, Hwang JJ, et al. Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30692096 DOI: 10.1158/1078-0432.Ccr-18-3388 |
0.01 |
|
| 2019 |
Kuang Xiao-Yu, Zhang Wu, Morgenstern-Badarau I. Analysis of temperature-dependent electron-paramagnetic-resonance spectra for S-state ions in MgO. Physical Review. B, Condensed Matter. 45: 8104-8107. PMID 10000623 DOI: 10.1103/PhysRevB.45.8104 |
0.01 |
|
| 2019 |
Puccini A, Poorman K, Salem ME, Goldberg RM, Shields AF, Berger MD, Battaglin F, Tokunaga R, Naseem M, Zhang W, Soni S, Korn WM, Philip PA, Marshall J, Lenz H. Comprehensive molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon. Journal of Clinical Oncology. 37: 63-63. DOI: 10.1200/Jco.2019.37.4_Suppl.63 |
0.01 |
|
| 2019 |
Naseem M, Xiu J, Salem ME, Goldberg RM, Vanderwalde AM, Grothey A, Philip PA, Seeber A, Puccini A, Tokunaga R, Battaglin F, Berger MD, Barzi A, Hanna DL, Zhang W, et al. Characteristics of colorectal cancer (CRC) patients with BRCA1 and BRCA2 mutations. Journal of Clinical Oncology. 37: 606-606. DOI: 10.1200/Jco.2019.37.4_Suppl.606 |
0.01 |
|
| 2019 |
Tokunaga R, Cao S, Battaglin F, Lo JH, Loupakis F, Stintzing S, Naseem M, Puccini A, Berger MD, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, et al. Th17 cell pathway-related genetic variants in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC, and FIRE-3. Journal of Clinical Oncology. 37: 594-594. DOI: 10.1200/Jco.2019.37.4_Suppl.594 |
0.01 |
|
| 2019 |
Battaglin F, Loupakis F, Stintzing S, Cao S, Puccini A, Tokunaga R, Naseem M, Berger MD, Soni S, Lo JH, Bergamo F, Lonardi S, Millstein J, Zhang W, Zagonel V, et al. Polymorphisms in the telomerase complex to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from TRIBE and FIRE-3 phase III trials. Journal of Clinical Oncology. 37: 566-566. DOI: 10.1200/JCO.2019.37.4_SUPPL.566 |
0.01 |
|
| 2019 |
Battaglin F, Puccini A, Cao S, Millstein J, Tokunaga R, Naseem M, Soni S, Lo JH, Ning T, Arai H, Berger MD, Barzi A, Zhang W, Heinemann V, Stintzing S, et al. Genetic variants in the lipopolysaccharide (LPS) receptor complex and TLR4 expression levels to predict efficacy of cetuximab (cet) in patients (pts) with metastatic colorectal cancer (mCRC): Data from the FIRE-3 phase III trial. Journal of Clinical Oncology. 37: 564-564. DOI: 10.1200/JCO.2019.37.4_suppl.564 |
0.01 |
|
| 2019 |
Berger MD, Stintzing S, Heinemann V, Cao S, Miyamoto Y, Suenaga M, Hanna DL, Soni S, Puccini A, Tokunaga R, Naseem M, Battaglin F, Zhang W, Cremolini C, Falcone A, et al. Genetic variations within the CD40L immune stimulating gene predict outcome for mCRC patients treated with first-line FOLFIRI/bevacizumab: Data from FIRE-3 and TRIBE. Journal of Clinical Oncology. 37: 558-558. DOI: 10.1200/JCO.2019.37.4_SUPPL.558 |
0.01 |
|
| 2019 |
Suenaga M, Cao S, Zhang W, Matsusaka S, Okazaki S, Berger MD, Miyamoto Y, Schirripa M, Barzi A, Ueno M, Lenz H. Role of enterocyte-specific gene polymorphisms in adjuvant treatment for stage III colorectal cancer. Journal of Clinical Oncology. 37: 550-550. DOI: 10.1200/JCO.2019.37.4_suppl.550 |
0.01 |
|
| 2019 |
Tokunaga R, Xiu J, Goldberg RM, Philip PA, Seeber A, Battaglin F, Arai H, Lo JH, Puccini A, Naseem M, Berger MD, Soni S, Zhang W, Chen WS, Hwang JJ, et al. Gene mutations of SWI/SNF complex and molecular profile in colorectal cancer. Journal of Clinical Oncology. 37: 3600-3600. DOI: 10.1200/Jco.2019.37.15_Suppl.3600 |
0.01 |
|
| 2019 |
Battaglin F, Cao S, Puccini A, Tokunaga R, Naseem M, Arai H, Berger MD, Ning T, Soni S, Lo JH, Barzi A, Millstein J, Zhang W, Heinemann V, Stintzing S, et al. Gene expression and genetic variants in Parkinson's disease (PD) genes to predict outcome in metastatic colorectal cancer (mCRC): Data from FIRE-3 phase III trial. Journal of Clinical Oncology. 37: 3595-3595. DOI: 10.1200/JCO.2019.37.15_SUPPL.3595 |
0.01 |
|
| 2019 |
Arai H, Cao S, Loupakis F, Stintzing S, Tokunaga R, Battaglin F, Lo JH, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, Cremolini C, et al. Genetic variants in RNA binding protein (RBP) to predict outcome in metastatic colorectal cancer (mCRC): Data from FIRE-3, TRIBE, and MAVERICC trials. Journal of Clinical Oncology. 37: 3545-3545. DOI: 10.1200/Jco.2019.37.15_Suppl.3545 |
0.01 |
|
| 2019 |
Naseem M, Cao S, Stintzing S, Loupakis F, Berger MD, Puccini A, Tokunaga R, Battaglin F, Barzi A, Soni S, Millstein J, Salem ME, Cremolini C, Zhang W, Heinemann V, et al. BRCA1 genetic variant to predict survival in metastatic colorectal cancer (mCRC) patients (pts) treated with FOLFIRI/bevacizumab (bev): Results from phase III TRIBE and FIRE-3 trials. Journal of Clinical Oncology. 37: 3145-3145. DOI: 10.1200/JCO.2019.37.15_SUPPL.3145 |
0.01 |
|
| 2019 |
Puccini A, Xiu J, Goldberg RM, Grothey A, Shields AF, Salem ME, Seeber A, Battaglin F, Berger MD, El-Deiry WS, Tokunaga R, Naseem M, Zhang W, Arora SP, Khushman MM, et al. Molecular differences between lymph nodes (LNs) and distant metastases (mets) in colorectal cancer (CRC). Journal of Clinical Oncology. 37: 3130-3130. DOI: 10.1200/Jco.2019.37.15_Suppl.3130 |
0.01 |
|
| 2019 |
Battaglin F, Cao S, Loupakis F, Stintzing S, Parikh AR, Puccini A, Tokunaga R, Naseem M, Berger MD, Arai H, Millstein J, Lonardi S, Zhang W, Cremolini C, Mancao C, et al. Polymorphisms in the dopamine (DA) signaling to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from TRIBE, MAVERICC, and FIRE-3 phase III trials. Journal of Clinical Oncology. 37: 3048-3048. DOI: 10.1200/JCO.2019.37.15_SUPPL.3048 |
0.01 |
|
| 2019 |
Berger MD, Cao S, Zlobec I, Miyamoto Y, Suenaga M, Hanna DL, Soni S, Puccini A, Tokunaga R, Naseem M, Battaglin F, Zhang W, Lugli A, Lenz H. Association of genetic variations within the T-cell costimulatory LIGHT gene with outcome in stage II and III colon cancer. Journal of Clinical Oncology. 37: 2633-2633. DOI: 10.1200/JCO.2019.37.15_SUPPL.2633 |
0.01 |
|
| 2019 |
Battaglin F, Xiu J, Baca Y, Goldberg RM, Grothey A, Shields AF, Seeber A, Salem ME, Puccini A, Tokunaga R, Naseem M, Arai H, Wang J, Berger MD, Zhang W, et al. Comprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC) Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz268.009 |
0.01 |
|
| 2019 |
Puccini A, Loupakis F, Stintzing S, Cao S, Millstein J, Battaglin F, Berger M, Togunaka R, Naseem M, Zhang W, Cremolini C, Falcone A, Heinemann V, Lenz H. Genetic variants in the one-carbon metabolism pathway to predict outcome in patients with metastatic colorectal cancer (mCRC): Data from TRIBE and FIRE-3 phase III trials Annals of Oncology. 30: v763-v764. DOI: 10.1093/annonc/mdz268.007 |
0.01 |
|
| 2019 |
Wang J, Xiu J, Arai H, Battaglin F, Poorman K, Tokunaga R, Zhang W, Korn W, Lenz H. Large-scale analysis of CDH1 mutations define a distinctive molecular subset in gastric cancer (GC) Annals of Oncology. 30: v258. DOI: 10.1093/annonc/mdz247.007 |
0.01 |
|
| 2018 |
Wang F, Lin Z, Yu W, Hu Q, Shu C, Zhang W. Copper-catalyzed C-H acyloxylation of 2-phenylpyridine using oxygen as the oxidant. Rsc Advances. 8: 16378-16382. PMID 35542218 DOI: 10.1039/c8ra01974f |
0.01 |
|
| 2018 |
Battaglin F, Puccini A, Naseem M, Schirripa M, Berger MD, Tokunaga R, McSkane M, Khoukaz T, Soni S, Zhang W, Lenz HJ. Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives. Journal of Cancer Metastasis and Treatment. 4. PMID 34532592 DOI: 10.20517/2394-4722.2018.04 |
0.01 |
|
| 2018 |
Li WW, Han Y, Yin YL, Wu QY, Zhang WU, Jiang WJ, Xia XY. [Multiplex fluorescence PCR for detection of Y Chromesome microdeletions]. Zhonghua Nan Ke Xue = National Journal of Andrology. 24: 1011-1015. PMID 32212476 |
0.01 |
|
| 2018 |
Suenaga M, Stintzing S, Cao S, Zhang W, Yang D, Ning Y, Okazaki S, Berger MD, Miyamoto Y, Schirripa M, Soni S, Barzi A, Heinemann V, Lenz HJ. Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial. European Journal of Cancer (Oxford, England : 1990). 107: 100-114. PMID 30554073 DOI: 10.1016/j.ejca.2018.11.019 |
0.01 |
|
| 2018 |
Tokunaga R, Naseem M, Lo JH, Battaglin F, Soni S, Puccini A, Berger MD, Zhang W, Baba H, Lenz HJ. B cell and B cell-related pathways for novel cancer treatments. Cancer Treatment Reviews. 73: 10-19. PMID 30551036 DOI: 10.1016/j.ctrv.2018.12.001 |
0.01 |
|
| 2018 |
Shi T, Qin F, Li Q, Zhang W. Copper-catalyzed three-component synthesis of pyrimidines from amidines and alcohols. Organic & Biomolecular Chemistry. PMID 30516789 DOI: 10.1039/c8ob02694g |
0.01 |
|
| 2018 |
Suenaga M, Cao S, Zhang W, Yang D, Ning Y, Okazaki S, Berger MD, Miyamoto Y, Schirripa M, Soni S, Barzi A, Yamaguchi T, Lenz HJ. Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients. International Journal of Cancer. PMID 30411783 DOI: 10.1002/ijc.31968 |
0.01 |
|
| 2018 |
Hussain M, Zhu W, Zhang W, Abidi SMR. Student Engagement Predictions in an e-Learning System and Their Impact on Student Course Assessment Scores. Computational Intelligence and Neuroscience. 2018: 6347186. PMID 30369946 DOI: 10.1155/2018/6347186 |
0.01 |
|
| 2018 |
Tokunaga R, Cao S, Naseem M, Lo JH, Battaglin F, Puccini A, Berger MD, Soni S, Millstein J, Zhang W, Stintzing S, Loupakis F, Cremolini C, Heinemann V, Falcone A, et al. Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy. Clinical Colorectal Cancer. PMID 30293873 DOI: 10.1016/j.clcc.2018.09.003 |
0.01 |
|
| 2018 |
Sunakawa Y, Mogushi K, Lenz HJ, Zhang W, Tsuji A, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Tanioka H, Negoro Y, Moran M, et al. Tumor sidedness and enriched gene groups for efficacy of first-line cetuximab treatment in metastatic colorectal cancer. Molecular Cancer Therapeutics. PMID 30275242 DOI: 10.1158/1535-7163.MCT-18-0694 |
0.01 |
|
| 2018 |
Zhang W, Mai C, Chen H, Zhang H. Impulsiveness in Reactive Dieters: Evidence From Delay Discounting in Orthodontic Patients. Frontiers in Human Neuroscience. 12: 347. PMID 30233343 DOI: 10.3389/fnhum.2018.00347 |
0.01 |
|
| 2018 |
Sunakawa Y, Yang D, Cao S, Zhang W, Moran M, Astrow SH, Hsiang J, Stephens C, Tsuji A, Takahashi T, Tanioka H, Negoro Y, Takagane A, Tani S, Yamaguchi T, et al. Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer. Clinical Colorectal Cancer. PMID 30219280 DOI: 10.1016/j.clcc.2018.08.002 |
0.01 |
|
| 2018 |
Zhang W, Zhao C, Zhao J, Zhu Y, Weng X, Chen Q, Sun H, Mi JQ, Li J, Zhu J, Chen Z, Pandolfi PP, Chen S, Yan X, Xu J. Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival. Theranostics. 8: 4359-4371. PMID 30214626 DOI: 10.7150/Thno.26900 |
0.01 |
|
| 2018 |
Yu SH, Zhu KY, Chen J, Liu XZ, Xu PF, Zhang W, Yan L, Guo HZ, Zhu J. JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML. Nature Communications. 9: 3369. PMID 30135572 DOI: 10.1038/s41467-018-05548-z |
0.01 |
|
| 2018 |
Ni J, Li Y, Zhang W, Shu R, Zhong Z. Sodium fluoride causes oxidative stress and apoptosis in cementoblasts. Chemico-Biological Interactions. PMID 30130527 DOI: 10.1016/j.cbi.2018.08.021 |
0.01 |
|
| 2018 |
Stanczak MA, Siddiqui SS, Trefny MP, Thommen DS, Boligan KF, von Gunten S, Tzankov A, Tietze L, Lardinois D, Heinzelmann-Schwarz V, von Bergwelt-Baildon MS, Zhang W, Lenz HJ, Han Y, Amos CI, et al. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. The Journal of Clinical Investigation. PMID 30130255 DOI: 10.1172/Jci120612 |
0.01 |
|
| 2018 |
Zhang W, Zhao JM, Lin J, Hu CZ, Zhang WB, Yang WL, Zhang J, Zhang JW, Zhu J. Adaptive Fibrogenic Reprogramming of Osteosarcoma Stem Cells Promotes Metastatic Growth. Cell Reports. 24: 1266-1277.e5. PMID 30067981 DOI: 10.1016/J.Celrep.2018.06.103 |
0.01 |
|
| 2018 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Cremolini C, Lonardi S, Bergamo F, Ning Y, Yamamoto N, Okazaki S, Berger MD, Miyamoto Y, Gopez R, Barzi A, et al. Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer. The Pharmacogenomics Journal. PMID 29925895 DOI: 10.1038/s41397-018-0030-8 |
0.01 |
|
| 2018 |
Zheng MM, Cao HR, Zhang WY, Yan PP, Xu JY, Zhao HL, Zhu F, Zhang JJ, Li Y, Zhu H. Abnormal gene methylation during embryonic development after preimplantation genetic testing increases risk of liver-derived insulin resistance. Annals of the New York Academy of Sciences. PMID 29873092 DOI: 10.1111/nyas.13700 |
0.01 |
|
| 2018 |
Wu Y, Guo T, Shu D, Zhang W, Luan F, Shi L, Guo D. Synthesis and luminescence properties of novel 8-hydroxyquinoline derivatives and their Eu(III) complexes. Luminescence : the Journal of Biological and Chemical Luminescence. PMID 29665234 DOI: 10.1002/bio.3482 |
0.01 |
|
| 2018 |
Hanna DL, Loupakis F, Yang D, Cremolini C, Schirripa M, Li M, Matsusaka S, Berger MD, Miyamoto Y, Zhang W, Ning Y, Antoniotti C, Salvatore L, Moran M, Zeger G, et al. Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. Clinical Colorectal Cancer. PMID 29636300 DOI: 10.1016/j.clcc.2018.03.006 |
0.01 |
|
| 2018 |
Naseem M, Barzi A, Brezden-Masley C, Puccini A, Berger MD, Tokunaga R, Battaglin F, Soni S, McSkane M, Zhang W, Lenz HJ. Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treatment Reviews. 66: 15-22. PMID 29631196 DOI: 10.1016/j.ctrv.2018.03.006 |
0.01 |
|
| 2018 |
Cao Y, Zhang W, Wang W. Spatial-temporal characteristics of haze and vertical distribution of aerosols over the Yangtze River Delta of China. Journal of Environmental Sciences (China). 66: 12-19. PMID 29628078 DOI: 10.1016/j.jes.2017.05.039 |
0.01 |
|
| 2018 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Ning Y, Cremolini C, Antoniotti C, Borelli B, Mashima T, Okazaki S, Berger MD, Miyamoto Y, Gopez R, Barzi A, et al. Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib. Clinical Colorectal Cancer. PMID 29606345 DOI: 10.1016/j.clcc.2018.02.010 |
0.01 |
|
| 2018 |
Cao Y, Zhang W, Wang W. Evaluation of TRMM 3B43 data over the Yangtze River Delta of China. Scientific Reports. 8: 5290. PMID 29593224 DOI: 10.1038/s41598-018-23603-z |
0.01 |
|
| 2018 |
Schirripa M, Zhang W, Yang D, Cao S, Okazaki S, Loupakis F, Berger MD, Ning Y, Miyamoto Y, Suenaga M, Alberti G, West JD, Lonardi S, Khoukaz T, Bergamo F, et al. NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients. Plos One. 13: e0193640. PMID 29522543 DOI: 10.1371/journal.pone.0193640 |
0.01 |
|
| 2018 |
Ding SM, Lu AL, Zhang W, Zhou L, Xie HY, Zheng SS, Li QY. The role of cancer-associated fibroblast MRC-5 in pancreatic cancer. Journal of Cancer. 9: 614-628. PMID 29483967 DOI: 10.7150/jca.19614 |
0.01 |
|
| 2018 |
Zhang Z, Zhao S, Li X, Zhuo X, Zhang W, Nie Q, Wang S, Yan L, Sun Y. Amentoflavone Inhibits Osteoclastogenesis and Wear Debris-Induced Osteolysis via Suppressing NF-κB and MAPKs Signaling Pathways. Planta Medica. PMID 29301147 DOI: 10.1055/s-0043-124594 |
0.01 |
|
| 2018 |
Schulz C, Zhang W, Lenz H, Neumann J, Kullmann F, Kunzmann V, Fuchs M, Heinemann V, Holch JW, Stintzing S. Germline polymorphisms (SNPs) to predict toxicity and efficacy in FLOT-treated patients with locally advanced gastroesophageal junction or gastric adenocarcinoma—data from the NeoFLOT study Translational Cancer Research. 7: 1393-1405. DOI: 10.21037/tcr.2018.11.03 |
0.01 |
|
| 2018 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Ning Y, Bergamo F, Zagonel V, Rossini D, Borelli B, Okazaki S, Berger MD, Miyamoto Y, Gopez R, Barzi A, et al. Matrix metalloproteinase-related gene polymorphisms to predict efficacy of regorafenib in patients with metastatic colorectal cancer. Journal of Clinical Oncology. 36: 692-692. DOI: 10.1200/JCO.2018.36.4_SUPPL.692 |
0.01 |
|
| 2018 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Cremolini C, Murgioni S, Lonardi S, Ning Y, Okazaki S, Berger MD, Miyamoto Y, Gopez R, Barzi A, Loupakis F, et al. Single nucleotide polymorphisms in miRNA binding sites of nucleotide excision repair-related genes to predict clinical benefit of oxaliplatin in FOLFOXIRI plus bevacizumab in TRIBE trial. Journal of Clinical Oncology. 36: 663-663. DOI: 10.1200/JCO.2018.36.4_suppl.663 |
0.01 |
|
| 2018 |
Naseem M, Berger MD, Puccini A, Tokunaga R, BATTAGLIN F, Barzi A, Soni S, McSkane M, Cao S, Millstein J, Zhang W, Loupakis F, Stintzing S, Heinemann V, Falcone A, et al. Polymorphisms in beta-defensin pathways and clinical outcomes in metastatic colorectal cancer patients treated with FOLFIRI-bevacizumab in two randomized phase III trials. Journal of Clinical Oncology. 36: 662-662. DOI: 10.1200/JCO.2018.36.4_suppl.662 |
0.01 |
|
| 2018 |
Tokunaga R, Cao S, Zhang W, Puccini A, Berger MD, Naseem M, BATTAGLIN F, Soni S, McSkane M, Stintzing S, Loupakis F, Heinemann V, Falcone A, Millstein J, Lenz HJ. The impact of Tfh cell/ B cell pathway-related genetic variants in metastatic colorectal cancer patients with bevacizumab-based chemotherapy. Journal of Clinical Oncology. 36: 651-651. DOI: 10.1200/JCO.2018.36.4_SUPPL.651 |
0.01 |
|
| 2018 |
Puccini A, Loupakis F, Stintzing S, Berger MD, Tokunaga R, Naseem M, BATTAGLIN F, Cao S, Millstein J, Soni S, McSkane M, Zhang W, Heinemann V, Falcone A, Lenz H. Genetic variants in methylation and demethylation pathways to predict clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI/Bev: Data from TRIBE and FIRE-3 trials. Journal of Clinical Oncology. 36: 646-646. DOI: 10.1200/JCO.2018.36.4_SUPPL.646 |
0.01 |
|
| 2018 |
Puccini A, Berger MD, Tokunaga R, Naseem M, BATTAGLIN F, Cao S, Millstein J, Soni S, McSkane M, Zhang W, Loupakis F, Stintzing S, Heinemann V, Falcone A, Lenz H. Polymorphism in cancer-associated fibroblasts (CAFs) related genes and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) enrolled in two independent randomized phase III trials: TRIBE and FIRE-3. Journal of Clinical Oncology. 36: 645-645. DOI: 10.1200/JCO.2018.36.4_SUPPL.645 |
0.01 |
|
| 2018 |
Berger MD, Zlobec I, Yang D, Cao S, Sunakawa Y, Matsusaka S, Koelzer VH, Inderbitzin D, Ning Y, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, Soni S, Puccini A, ... ... Zhang W, et al. Association of genetic variations within the PD-L2 immune checkpoint gene with outcome in stage II and III colon cancer. Journal of Clinical Oncology. 36: 626-626. DOI: 10.1200/JCO.2018.36.4_suppl.626 |
0.01 |
|
| 2018 |
Tokunaga R, Cao S, Puccini A, Naseem M, Battaglin F, Barzi A, Millsteinand J, Soni S, Berger MD, McSkane M, Zhang W, Loupakis F, Cremolini C, Falcone A, Lenz H. The impact of Th17 cell pathway-related genetic variants in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy. Journal of Clinical Oncology. 36: e15578-e15578. DOI: 10.1200/jco.2018.36.15_suppl.e15578 |
0.01 |
|
| 2018 |
Puccini A, Poorman K, Salem ME, Goldberg RM, Shields AF, Xiu J, Korn WM, Seeber A, Berger MD, Tokunaga R, Naseem M, Battaglin F, Barzi A, Iqbal S, Zhang W, et al. Comprehensive genomic profiling of 724 gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Journal of Clinical Oncology. 36: 4098-4098. DOI: 10.1200/Jco.2018.36.15_Suppl.4098 |
0.01 |
|
| 2018 |
Tokunaga R, Xiu J, Johnston C, Goldberg RM, Philip PA, Seeber A, Puccini A, Naseem M, Battaglin F, Berger MD, Soni S, McSkane M, Barzi A, Zhang W, Hwang JJ, et al. Molecular characterization of appendiceal cancer and comparison with right-sided (R-CRC) and left-sided colorectal cancer (L-CRC). Journal of Clinical Oncology. 36: 3611-3611. DOI: 10.1200/Jco.2018.36.15_Suppl.3611 |
0.01 |
|
| 2018 |
Battaglin F, Cao S, Millstein J, Puccini A, Tokunaga R, Naseem M, Soni S, McSkane M, Berger MD, Barzi A, Zhang W, Zagonel V, Cremolini C, Stintzing S, Loupakis F, et al. Polymorphism in the circadian clock pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from TRIBE and FIRE-3 phase III trials. Journal of Clinical Oncology. 36: 3576-3576. DOI: 10.1200/jco.2018.36.15_suppl.3576 |
0.01 |
|
| 2018 |
Gruber SB, Schmit S, Melas M, Qu C, Heinemann V, Stintzing S, Falcone A, Loupakis F, Mancao C, Cao S, Cremolini C, Conti DV, Zhang W, Lenz H. Genetic variation in TET3 and survival in metastatic colorectal cancer (mCRC) from FIRE-3, TRIBE, and MAVERICC clinical trials. Journal of Clinical Oncology. 36: 3575-3575. DOI: 10.1200/Jco.2018.36.15_Suppl.3575 |
0.01 |
|
| 2018 |
Naseem M, Stintzing S, Cao S, Puccini A, Tokunaga R, Battaglin F, Barzi A, Berger MD, Soni S, McSkane M, Zhang W, Millstein J, Heinemann V, Lenz H. Genetic variations in the β2M/HLA-E immunomodulatory complex to predict outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line FOLFIRI/Cetuximab: Data from the phase III FIRE-3 trial. Journal of Clinical Oncology. 36: 12107-12107. DOI: 10.1200/jco.2018.36.15_suppl.12107 |
0.01 |
|
| 2018 |
Battaglin F, Xiu J, Winerip M, Goldberg RM, Philip PA, Seeber A, Puccini A, Tokunaga R, Naseem M, Soni S, McSkane M, Berger MD, Barzi A, Zhang W, Hwang JJ, et al. Circadian clock gene PER1 mutations in colorectal cancer (CRC). Journal of Clinical Oncology. 36: 12106-12106. DOI: 10.1200/Jco.2018.36.15_Suppl.12106 |
0.01 |
|
| 2018 |
Puccini A, Loupakis F, Cao S, Tokunaga R, Naseem M, Battaglin F, Berger MD, McSkane M, Soni S, Zhang W, Millstein J, Mancao C, Cremolini C, Falcone A, Lenz H. Genetic variants within the glucocorticoids related genes to predict outcome in patients with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 36: 12098-12098. DOI: 10.1200/JCO.2018.36.15_SUPPL.12098 |
0.01 |
|
| 2018 |
Suenaga M, Schirripa M, Loupakis F, Cao S, Zhang W, Cremolini C, Lonardi S, Okazaki S, Berger MD, Miyamoto Y, Soni S, Barzi A, Yamaguchi T, Falcone A, Lenz H. Clinical significance of enterocyte-specific gene polymorphisms as candidate marker of oxaliplatin-based treatment for metastatic colorectal cancer. Journal of Clinical Oncology. 36: 12066-12066. DOI: 10.1200/jco.2018.36.15_suppl.12066 |
0.01 |
|
| 2017 |
Cai JZ, Zhang W. [Studies on the Interaction of Poly-L-lysine with Fibrinogen with Spectroscopic Methods]. Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu. 37: 166-71. PMID 30196004 |
0.01 |
|
| 2017 |
Zhang W, Liu F. Effect of Polylysine on Blood Clotting, and Red Blood Cell Morphology, Aggregation and Hemolysis. Journal of Nanoscience and Nanotechnology. 17: 251-55. PMID 29620337 |
0.01 |
|
| 2017 |
Cen WJ, Feng Y, Li SS, Huang WL, Zhang T, Zhang W, Kong WD, Jiang JW. Iron overload induces G1 phase arrest and autophagy in murine preosteoblast cells. Journal of Cellular Physiology. PMID 29244196 DOI: 10.1002/jcp.26405 |
0.01 |
|
| 2017 |
Berger MD, Stintzing S, Heinemann V, Cao S, Yang D, Sunakawa Y, Matsusaka S, Ning Y, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, Hanna DL, Soni S, Puccini A, ... Zhang W, et al. A polymorphism within the vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab or FOLFIRI/cetuximab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29208668 DOI: 10.1158/1078-0432.CCR-17-1663 |
0.01 |
|
| 2017 |
Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H, Lenz HJ. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treatment Reviews. 63: 40-47. PMID 29207310 DOI: 10.1016/j.ctrv.2017.11.007 |
0.01 |
|
| 2017 |
Miyamoto Y, Zhang W, Lenz HJ. Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer. Indian Journal of Surgical Oncology. 8: 580-590. PMID 29203992 DOI: 10.1007/s13193-016-0543-z |
0.01 |
|
| 2017 |
Han Q, Wen Y, Liu JC, Zhang W, Chen LJ, Zhao JW. Rare-Earth-Incorporated Tellurotungstate Hybrids Functionalized by 2-Picolinic Acid Ligands: Syntheses, Structures, and Properties. Inorganic Chemistry. PMID 29048174 DOI: 10.1021/acs.inorgchem.7b02009 |
0.01 |
|
| 2017 |
Cai J, Zhang W, Xu J, Xue W, Liu Z. Evaluation of N-phosphonium chitosan as a novel vaccine carrier for intramuscular immunization. Journal of Biomaterials Applications. 885328217735221. PMID 28992775 DOI: 10.1177/0885328217735221 |
0.01 |
|
| 2017 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Dadduzio V, Salvatore L, Borelli B, Pietrantonio F, Ning Y, Okazaki S, Berger MD, Miyamoto Y, Gopez R, Barzi A, et al. Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer. European Journal of Cancer (Oxford, England : 1990). 86: 197-206. PMID 28992563 DOI: 10.1016/j.ejca.2017.08.033 |
0.01 |
|
| 2017 |
Hu Q, Liu X, Wang G, Wang F, Li Q, Zhang W. Ag1Pd1 nanoparticles-reduced graphene oxide as highly efficient and recyclable catalyst for direct aryl C-H olefination. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 28949081 DOI: 10.1002/chem.201704056 |
0.01 |
|
| 2017 |
Puccini A, Berger MD, Naseem M, Tokunaga R, Battaglin F, Cao S, Hanna DL, McSkane M, Soni S, Zhang W, Lenz HJ. Colorectal cancer: Epigenetic alterations and their clinical implications. Biochimica Et Biophysica Acta. PMID 28939182 DOI: 10.1016/j.bbcan.2017.09.003 |
0.01 |
|
| 2017 |
Ji Y, Li G, Zhang W, Ma D, Xue W. Cross-linked branched polyethylenimine used as a nitric oxide donor for prolonged nitric oxide release. Materials Science & Engineering. C, Materials For Biological Applications. 81: 492-499. PMID 28888003 DOI: 10.1016/j.msec.2017.08.037 |
0.01 |
|
| 2017 |
Wang WF, Yan L, Liu Z, Liu LX, Lin J, Liu ZY, Chen XP, Zhang W, Xu ZZ, Shi T, Li JM, Zhao YL, Meng G, Xia Y, Li JY, et al. HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells. Nature Communications. 8: 363. PMID 28842558 DOI: 10.1038/s41467-017-00476-w |
0.01 |
|
| 2017 |
Okazaki S, Schirripa M, Loupakis F, Cao S, Zhang W, Yang D, Ning Y, Berger MD, Miyamoto Y, Suenaga M, Iqubal S, Barzi A, Cremolini C, Falcone A, Battaglin F, et al. Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Cancer. PMID 28708932 DOI: 10.1002/cncr.30880 |
0.01 |
|
| 2017 |
Ran S, Sun N, Liu Y, Zhang W, Li Y, Wei L, Wang J, Liu B. Fluoride resistance capacity in mammalian cells involves complex global gene expression changes. Febs Open Bio. 7: 968-980. PMID 28680810 DOI: 10.1002/2211-5463.12236 |
0.01 |
|
| 2017 |
Zhang P, Zhang W, Wang J, Jiang K, Zhang J, Li W, Wu J, Hu Z, Chu J. The electro-optic mechanism and infrared switching dynamic of the hybrid multilayer VO2/Al:ZnO heterojunctions. Scientific Reports. 7: 4425. PMID 28667297 DOI: 10.1038/s41598-017-04660-2 |
0.01 |
|
| 2017 |
Wang F, Hu Q, Shu C, Lin Z, Min D, Shi T, Zhang W. Copper-Catalyzed Direct Acyloxylation of C(sp(2))-H Bonds in Aromatic Amides. Organic Letters. PMID 28657322 DOI: 10.1021/acs.orglett.7b01559 |
0.01 |
|
| 2017 |
Okazaki S, Stintzing S, Sunakawa Y, Cao S, Zhang W, Yang D, Ning Y, Matsusaka S, Berger MD, Miyamoto Y, Suenaga M, Schirripa M, West JD, Gopez R, Akihito T, et al. Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer. International Journal of Cancer. PMID 28569041 DOI: 10.1002/ijc.30810 |
0.01 |
|
| 2017 |
Yang H, Guo HZ, Li XY, Lin J, Zhang W, Zhao JM, Zhang HX, Chen SJ, Chen Z, Zhu J. Viral RNA-Unprimed Rig-I Restrains Stat3 Activation in the Modulation of Regulatory T Cell/Th17 Cell Balance. Journal of Immunology (Baltimore, Md. : 1950). PMID 28550197 DOI: 10.4049/jimmunol.1700366 |
0.01 |
|
| 2017 |
Puccini A, Berger MD, Zhang W, Lenz HJ. What We Know About Stage II and III Colon Cancer: It's Still Not Enough. Targeted Oncology. PMID 28504299 DOI: 10.1007/s11523-017-0494-5 |
0.01 |
|
| 2017 |
Liu X, Chen J, Yu S, Yan L, Guo H, Dai J, Zhang W, Zhu J. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells. Cell Death & Disease. 8: e2782. PMID 28492552 DOI: 10.1038/cddis.2017.197 |
0.01 |
|
| 2017 |
Schirripa M, Zhang W, Heinemann V, Cao S, Okazaki S, Yang D, Loupakis F, Berger MD, Ning Y, Miyamoto Y, Suenaga M, Gopez RF, West JD, Hanna D, Barzi A, et al. Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial. International Journal of Cancer. PMID 28369940 DOI: 10.1002/ijc.30715 |
0.01 |
|
| 2017 |
Berger MD, Yamauchi S, Cao S, Hanna DL, Sunakawa Y, Schirripa M, Matsusaka S, Yang D, Groshen S, Zhang W, Ning Y, Okazaki S, Miyamoto Y, Suenaga M, Lonardi S, et al. Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials. European Journal of Cancer (Oxford, England : 1990). 77: 13-20. PMID 28347919 DOI: 10.1016/J.Ejca.2017.02.020 |
0.01 |
|
| 2017 |
Shin M, Chen JW, Tsai CY, Aprecio R, Zhang W, Yochim JM, Teng N, Torabinejad M. Cytotoxicity and Antimicrobial Effects of a New Fast-Set MTA. Biomed Research International. 2017: 2071247. PMID 28303246 DOI: 10.1155/2017/2071247 |
0.01 |
|
| 2017 |
Sun XN, Li C, Liu Y, Du LJ, Zeng MR, Zheng XJ, Zhang WC, Liu Y, Zhu M, Kong D, Zhou L, Lu L, Shen ZX, Yi Y, Du L, et al. T Cell Mineralocorticoid Receptor Controls Blood Pressure by Regulating Interferon Gamma. Circulation Research. PMID 28298295 DOI: 10.1161/Circresaha.116.310480 |
0.01 |
|
| 2017 |
Zhang W, Xu J. DNA methyltransferases and their roles in tumorigenesis. Biomarker Research. 5: 1. PMID 28127428 DOI: 10.1186/s40364-017-0081-z |
0.01 |
|
| 2017 |
Zhou X, Kattadiyil MT, Aprecio RM, Liu X, Zhang W, Li Y. Effect of opposing implant prostheses on periodontal pathogens in dentures: A pilot study. The Journal of Prosthetic Dentistry. PMID 28126355 DOI: 10.1016/j.prosdent.2016.10.011 |
0.01 |
|
| 2017 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Salvatore L, Lonardi S, Moretto R, Borelli B, Ning Y, Okazaki S, Berger MD, Miyamoto Y, Gopez R, Hanna DL, et al. Genetic variants of genes in CCL5/CCR5 pathway to predict regorafenib-induced hand-foot skin reaction in patients with refractory metastatic colorectal cancer: A report of ethnic difference. Journal of Clinical Oncology. 35: 615-615. DOI: 10.1200/JCO.2017.35.4_SUPPL.615 |
0.01 |
|
| 2017 |
Berger MD, Stintzing S, Yang D, Suenaga M, Miyamoto Y, Cao S, Soni S, Gopez R, Hanna DL, Zhang W, Heinemann V, Lenz H. Effect of polymorphisms of genes encoding regulatory proteins in the coagulation cascade on outcome for mCRC patients treated with FOLFIRI and bevacizumab: Data from FIRE-3 trial. Journal of Clinical Oncology. 35: 601-601. DOI: 10.1200/JCO.2017.35.4_suppl.601 |
0.01 |
|
| 2017 |
Miyamoto Y, Stintzing S, Zhang W, Cao S, Ning Y, Okazaki S, Berger MD, Suenaga M, Schirripa M, Soni S, Matsusaka S, Yang D, Gopez R, Hanna DL, Barzi A, et al. Polymorphisms in adipokine-related genes to predict treatment outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab-based chemotherapy. Journal of Clinical Oncology. 35: 600-600. DOI: 10.1200/JCO.2017.35.4_suppl.600 |
0.01 |
|
| 2017 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Marmorino F, Bergamo F, Antoniotti C, Rossini D, Ning Y, Okazaki S, Berger MD, Miyamoto Y, Gopez R, Hanna DL, et al. Role of genetic polymorphisms in CCL5/CCR5 axis to predict efficacy of regorafenib in patients with refractory metastatic colorectal cancer. Journal of Clinical Oncology. 35: 596-596. DOI: 10.1200/JCO.2017.35.4_SUPPL.596 |
0.01 |
|
| 2017 |
Berger MD, Stintzing S, Heinemann V, Yang D, Cao S, Ning Y, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, Gopez R, Hanna DL, Zhang W, Lenz H. Effect of JAK2 SNP rs2274472 on outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial. Journal of Clinical Oncology. 35: 595-595. DOI: 10.1200/JCO.2017.35.4_SUPPL.595 |
0.01 |
|
| 2017 |
Suenaga M, Cao S, Stintzing S, Zhang W, Yang D, Ning Y, Okazaki S, Berger MD, Miyamoto Y, Schirripa M, Gopez R, Melendez E, Soni S, Barzi A, Yamaguchi T, et al. Genetic polymorphisms of CCL5 and CCR5 to predict efficacy of cetuximab-based treatment in metastatic colorectal cancer patients depending on primary tumor location. Journal of Clinical Oncology. 35: 3594-3594. DOI: 10.1200/jco.2017.35.15_suppl.3594 |
0.01 |
|
| 2017 |
Miyamoto Y, Stintzing S, Heinemann V, Zhang W, Cao S, Okazaki S, Berger MD, Suenaga M, Schirripa M, Soni S, Matsusaka S, Ning Y, Yang D, Gopez R, Melendez E, et al. Association of genetic variations in genes implicated in the axis with outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with cetuximab plus chemotherapy. Journal of Clinical Oncology. 35: 3585-3585. DOI: 10.1200/jco.2017.35.15_suppl.3585 |
0.01 |
|
| 2017 |
Sunakawa Y, Yang D, LaFleur B, Luecke J, Thompson D, Moran M, Astrow SH, Hsiang J, Zhang W, Tsuji A, Takahashi T, Tanioka H, Negoro Y, Takagane A, Tani S, et al. Association of immune-related genes to neutrophil-lymphocyte ratio (NLR) with survival of cetuximab treatment for metastatic colorectal cancer (mCRC): JACCRO CC-05/06AR. Journal of Clinical Oncology. 35: 11613-11613. DOI: 10.1200/JCO.2017.35.15_SUPPL.11613 |
0.01 |
|
| 2017 |
Miyamoto Y, Loupakis F, Zhang W, Cao S, Okazaki S, Berger MD, Suenaga M, Schirripa M, Soni S, Matsusaka S, Ning Y, Yang D, Gopez R, Melendez E, Hanna DL, et al. Genetic variations in semaphorin/neuropilin signaling to predict clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab-based chemotherapy. Journal of Clinical Oncology. 35: 11608-11608. DOI: 10.1200/jco.2017.35.15_suppl.11608 |
0.01 |
|
| 2017 |
Suenaga M, Cao S, Zhang W, Ning Y, Okazaki S, Berger MD, Miyamoto Y, Schirripa M, Gopez R, Melendez E, Soni S, Barzi A, Yamaguchi T, Lenz H. Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels to predict efficacy of bevacizumab in metastatic colorectal cancer patients receiving first-line chemotherapy. Journal of Clinical Oncology. 35: 11564-11564. DOI: 10.1200/jco.2017.35.15_suppl.11564 |
0.01 |
|
| 2017 |
Berger MD, Stintzing S, Yang D, Cao S, Miyamoto Y, Suenaga M, Soni S, Gopez R, Melendez E, Zhang W, Heinemann V, Lenz H. Genetic variations within the vitamin C transporter genes to predict outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial. Journal of Clinical Oncology. 35: 11507-11507. DOI: 10.1200/JCO.2017.35.15_SUPPL.11507 |
0.01 |
|
| 2017 |
Ichikawa W, Mogushi K, Lenz H, Zhang W, Tsuji A, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Lafleur B, Luecke J, Thompson D, et al. Tumor sidedness and enriched gene groups for efficacy of 1st-line cetuximab (cet) treatment in metastatic colorectal cancer (mCRC) Annals of Oncology. 28: v199-v200. DOI: 10.1093/ANNONC/MDX393.114 |
0.01 |
|
| 2017 |
Stremitzer S, Vermeulen P, Kockx M, Dirix L, Graver S, Scherer S, Yang D, Zhang W, Stift J, Wrba F, Gruenberger T, Lenz H. 564PThe inflamed immune phenotype can be induced by systemic treatment in angiogenic colorectal liver metastases in contrast to non-angiogenic liver metastases Annals of Oncology. 28. DOI: 10.1093/Annonc/Mdx393.090 |
0.01 |
|
| 2016 |
Ma YX, Zhang W, Zhang LZ. [Cotton water requirement character during recent 30 years in China.] Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology. 27: 1541-1552. PMID 29732816 DOI: 10.13287/j.1001-9332.201605.038 |
0.01 |
|
| 2016 |
Wang Q, Zhang P, Aprecio R, Zhang D, Li H, Ji N, Mohamed O, Zhang W, Li Y, Ding Y. Comparison of Experimental Diabetic Periodontitis Induced by Porphyromonas gingivalis in Mice. Journal of Diabetes Research. 2016: 4840203. PMID 27995146 DOI: 10.1155/2016/4840203 |
0.01 |
|
| 2016 |
Yang X, Li H, Zhang W, Sun M, Li L, Xu N, Wu J, Sun J. High visible photoelectrochemical activity of Ag nanoparticle-sandwiched CdS/Ag/ZnO nanorods. Acs Applied Materials & Interfaces. PMID 27982560 DOI: 10.1021/Acsami.6B12259 |
0.01 |
|
| 2016 |
Jiang Z, Wang Y, Philippe M, Zhang W, Tian N, Zheng S. A Jurassic wood providing insights into the earliest step in Ginkgo wood evolution. Scientific Reports. 6: 38191. PMID 27982113 DOI: 10.1038/srep38191 |
0.01 |
|
| 2016 |
Kong WD, Ke JY, Hu XQ, Zhang W, Li SS, Feng Y. Applications of cone-beam computed tomography to assess the effects of labial crown morphologies and collum angles on torque for maxillary anterior teeth. American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics. 150: 789-795. PMID 27871705 DOI: 10.1016/j.ajodo.2016.03.029 |
0.01 |
|
| 2016 |
Li X, Wen A, Ma X, Chen W, Gao Y, Zhang W, Tu Z, Xiang S. Photonic microwave frequency measurement with a tunable range based on a dual-polarization modulator. Applied Optics. 55: 8727-8731. PMID 27828267 |
0.01 |
|
| 2016 |
Gao Y, Wen A, Tu Z, Zhang W, Lin L. Simultaneously photonic frequency downconversion, multichannel phase shifting, and IQ demodulation for wideband microwave signals. Optics Letters. 41: 4484-4487. PMID 27749861 |
0.01 |
|
| 2016 |
Xu J, Zhang W, Yan XJ, Lin XQ, Li W, Mi JQ, Li JM, Zhu J, Chen Z, Chen SJ. DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1. Journal of Hematology & Oncology. 9: 106. PMID 27724883 DOI: 10.1186/S13045-016-0337-3 |
0.01 |
|
| 2016 |
Wu L, Guo H, Sun H, Zhang W, Sun C, Wang J. UNC119 mediates gambogic acid-induced cell-cycle dysregulation through the Gsk3β/β-catenin pathway in hepatocellular carcinoma cells. Anti-Cancer Drugs. 27: 988-1000. PMID 27669172 DOI: 10.1097/CAD.0000000000000416 |
0.01 |
|
| 2016 |
Ke JY, Zhang W, Gong RS, Cen WJ, Huang HQ, Li YR, Kong WD, Jiang JW. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 27644244 DOI: 10.1007/s13277-016-5376-4 |
0.01 |
|
| 2016 |
Stremitzer S, Zhang W, Yang D, Ning Y, Sunakawa Y, Matsusaka S, Parekh A, Okazaki S, Hanna D, Astrow SH, Moran M, Hernandez J, Stephens C, Scherer SJ, Stift J, et al. Expression of genes involved in vascular morphogenesis and maturation predicts efficacy of bevacizumab-based chemotherapy in patients undergoing liver resection. Molecular Cancer Therapeutics. PMID 27535973 DOI: 10.1158/1535-7163.MCT-16-0275 |
0.01 |
|
| 2016 |
Berger MD, Yang D, Sunakawa Y, Zhang W, Ning Y, Matsusaka S, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, Lenz AM, Bohanes P, Barzi A, Figueiredo JC, Hanna DL, et al. Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012. Oncotarget. PMID 27449091 DOI: 10.18632/oncotarget.10696 |
0.01 |
|
| 2016 |
Miyamoto Y, Hanna DL, Zhang W, Baba H, Lenz HJ. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27340276 DOI: 10.1158/1078-0432.CCR-16-0495 |
0.01 |
|
| 2016 |
Labonte MJ, Yang D, Zhang W, Wilson PM, Nagarwala YM, Koch KM, Briner C, Kaneko T, Rha SY, Gladkov O, Urba SG, Sakaeva D, Pishvaian MJ, Hsieh RK, Lee WP, et al. A phase II biomarker-embedded study of lapatinib plus capecitabine as first-line therapy in patients with advanced or metastatic gastric cancer. Molecular Cancer Therapeutics. PMID 27325685 DOI: 10.1158/1535-7163.MCT-15-0908 |
0.01 |
|
| 2016 |
Zhang W, Xie HY, Ding SM, Xing CY, Chen A, Lai MC, Zhou L, Zheng SS. CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 15: 289-96. PMID 27298105 DOI: 10.1016/S1499-3872(16)60099-1 |
0.01 |
|
| 2016 |
Okazaki S, Loupakis F, Stintzing S, Cao S, Zhang W, Yang D, Ning Y, Sunakawa Y, Stremitzer S, Matsusaka S, Berger MD, Parekh A, West JD, Miyamoto Y, Suenaga M, et al. Clinical significance of TLR1 I602S polymorphism for patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab. Molecular Cancer Therapeutics. PMID 27196764 DOI: 10.1158/1535-7163.MCT-15-0931 |
0.01 |
|
| 2016 |
Sunakawa Y, Yang D, Moran M, Astrow SH, Tsuji A, Stephens C, Zhang W, Cao S, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, et al. Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer. Cancer Biology & Therapy. 0. PMID 27104867 DOI: 10.1080/15384047.2016.1178426 |
0.01 |
|
| 2016 |
Matsusaka S, Zhang W, Cao S, Hanna DL, Sunakawa Y, Sebio A, Ueno M, Yang D, Ning Y, Parekh A, Okazaki S, Berger MD, Ichikawa W, Mizunuma N, Lenz HJ. TWIST1 polymorphisms predict survival in patients with metastatic colorectal cancer receiving first-line bevacizumab plus oxaliplatin-based chemotherapy. Molecular Cancer Therapeutics. PMID 26983880 DOI: 10.1158/1535-7163.MCT-15-0751 |
0.01 |
|
| 2016 |
Matsusaka S, Hanna DL, Cao S, Zhang W, Yang D, Ning Y, Sunakawa Y, Okazaki S, Berger MD, Miyamoto Y, Parekh A, Stintzing S, Loupakis F, Lenz HJ. Prognostic Impact of IL-6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26839145 DOI: 10.1158/1078-0432.CCR-15-2422 |
0.01 |
|
| 2016 |
Sunakawa Y, Yang D, Cao S, Roberts C, Wang E, Moran M, Astrow SH, Thompson D, Hsiang J, Zhang W, Tsuji A, Takahashi T, Denda T, Kochi M, Shimada K, et al. Alteration of ADCC-related genes as a novel predictor of efficacy of cetuximab (cet)-based chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC) (JACCRO CC-05/06 AR). Journal of Clinical Oncology. 34: 589-589. DOI: 10.1200/JCO.2016.34.4_SUPPL.589 |
0.01 |
|
| 2016 |
Berger MD, Stintzing S, Heinemann V, Yang D, Sunakawa Y, Ning Y, Matsusaka S, Okazaki S, Miyamoto Y, Suenaga M, West JD, Zhang W, Petasis N, Lenz H. Serum amyloid α (SAA-1) SNP rs12218 to predict outcome for mCRC patients treated with FOLFIRI and bevacizumab: Data from FIRE-3 trial. Journal of Clinical Oncology. 34: 586-586. DOI: 10.1200/Jco.2016.34.4_Suppl.586 |
0.01 |
|
| 2016 |
Okazaki S, Stintzing S, Heinemann V, Cao S, Zhang W, Yang D, Ning Y, Matsusaka S, Berger MD, West JD, Miyamoto Y, Suenaga M, Lenz H. Association of TLR9 polymorphism with overall survival in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab enrolled in FIRE3. Journal of Clinical Oncology. 34: 498-498. DOI: 10.1200/JCO.2016.34.4_SUPPL.498 |
0.01 |
|
| 2016 |
Cao S, Yang D, Stintzing S, Loupakis F, Zhang W, Ning Y, Schirripa M, Suenaga M, Okazaki S, Miyamoto Y, Barzi A, Lenz H. Identifying predictive SNPs in patients with metastatic colorectal cancer (mCRC) using Random Survival Forests. Journal of Clinical Oncology. 34: 3606-3606. DOI: 10.1200/jco.2016.34.15_suppl.3606 |
0.01 |
|
| 2016 |
Yang D, Zhang W, Cao S, Loupakis F, Schirripa M, Stintzing S, Lenz H. Identifying SNPs associated with progression-free survival (PFS) and overall survival (OS) in patients with KRAS wildtype and mutant metastatic colorectal cancer (mCRC) using Random Survival Forests (RSF). Journal of Clinical Oncology. 34: 3604-3604. DOI: 10.1200/JCO.2016.34.15_SUPPL.3604 |
0.01 |
|
| 2016 |
West JD, Zhang W, Stintzing S, Sunakawa Y, Yang D, Cao S, Ning Y, Berger MD, Gopez R, Miyamoto Y, Okazaki S, Suenaga M, Schirripa M, Barzi A, Hanna DL, et al. Genetic variants in immune response genes to predict clinical outcome in mCRC patients treated with FOLFIRI/cetuximab (FIRE-3) or with first line cetuximab-based chemotherapy (JACCRO CC-05/06 AR). Journal of Clinical Oncology. 34: 3595-3595. DOI: 10.1200/jco.2016.34.15_suppl.3595 |
0.01 |
|
| 2016 |
Sunakawa Y, Wang E, Roberts C, Yang D, Liu Q, Thompson D, Botros I, Moran M, Astrow SH, Hsiang J, Zhang W, Stintzing S, Tsuji A, Takahashi T, Denda T, et al. Association of gene signature to identify molecular subtypes with clinical outcomes of 1st-line cetuximab (cet) treatment for metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 34: 3592-3592. DOI: 10.1200/JCO.2016.34.15_SUPPL.3592 |
0.01 |
|
| 2016 |
Miyamoto Y, Stintzing S, Loupakis F, Zhang W, Cao S, Ning Y, Okazaki S, Berger MD, Suenaga M, Schirripa M, Matsusaka S, Yang D, West JD, Gopez R, Hanna DL, et al. Genetic variations associated with cancer cachexia pathways to predict survival in metastatic colorectal cancer (mCRC): Results from FIRE-3 and TRIBE. Journal of Clinical Oncology. 34: 3590-3590. DOI: 10.1200/jco.2016.34.15_suppl.3590 |
0.01 |
|
| 2016 |
Okazaki S, Stintzing S, Sunakawa Y, Cao S, Zhang W, Yang D, Ning Y, Berger MD, West JD, Gopez R, Miyamoto Y, Suenaga M, Schirripa M, Barzi A, Hanna DL, et al. Polymorphisms in toll-like receptor (TLR) genes in the prediction of outcome for cetuximab-based treatment in patients with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 34: 3588-3588. DOI: 10.1200/JCO.2016.34.15_SUPPL.3588 |
0.01 |
|
| 2016 |
Ning Y, Stintzing S, Zhang W, Yang D, Hanna DL, Okazaki S, Berger MD, Miyamoto Y, West JD, Suenaga M, Schirripa M, Barzi A, Heinemann V, Lenz H. Genetic variants of R-spondin genes to predict clinical outcome in mCRC patients (pts) treated with first line FOLFIRI and bevacizumab (FOLFIRI/BEV) in FIRE-3 cohort. Journal of Clinical Oncology. 34: 3586-3586. DOI: 10.1200/jco.2016.34.15_suppl.3586 |
0.01 |
|
| 2016 |
Berger MD, Stintzing S, Heinemann V, Yang D, Sunakawa Y, Ning Y, Matsusaka S, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, West JD, Barzi A, Hanna DL, Zhang W, et al. Polymorphisms of genes encoding for vitamin D binding protein and Wnt5a to predict outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial. Journal of Clinical Oncology. 34: 3581-3581. DOI: 10.1200/jco.2016.34.15_suppl.3581 |
0.01 |
|
| 2016 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Berger MD, West JD, Ning Y, Salvatore L, Rossini D, Antoniotti C, Inoue R, Matsusaka S, Okazaki S, Miyamoto Y, et al. Genetic variants of ATM and XRCC3 to predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer. Journal of Clinical Oncology. 34: 3579-3579. DOI: 10.1200/JCO.2016.34.15_SUPPL.3579 |
0.01 |
|
| 2016 |
Schirripa M, Yang D, Loupakis F, Antoniotti C, Cremolini C, Cao S, Okazaki S, Berger MD, Ning Y, Miyamoto Y, Suenaga M, Moretto R, Bergamo F, Battaglin F, Lonardi S, ... ... Zhang W, et al. Females versus males: Clinical features and outcome differences in large molecularly selected cohort of mCRC patients. Journal of Clinical Oncology. 34: 3540-3540. DOI: 10.1200/JCO.2016.34.15_SUPPL.3540 |
0.01 |
|
| 2016 |
Gopez R, Schirripa M, Zhang W, Cao S, Okazaki S, Yang D, Loupakis F, Berger MD, Ning Y, Miyamoto Y, Suenaga M, West JD, Hanna DL, Barzi A, Falcone A, et al. IRS1 and IRS2 polymorphisms and outcome in mCRC patients enrolled in the FIRE-3 trial. Journal of Clinical Oncology. 34: 11600-11600. DOI: 10.1200/jco.2016.34.15_suppl.11600 |
0.01 |
|
| 2016 |
Schirripa M, Zhang W, Yang D, Cao S, Okazaki S, Loupakis F, Berger MD, Ning Y, Barzi A, Miyamoto Y, Suenaga M, Gopez R, West JD, Hanna DL, Lonardi S, et al. NOS2 polymorphisms in the prediction of benefit from FOLFIRI plus bevacizumab in mCRC patients enrolled in TRIBE trial. Journal of Clinical Oncology. 34: 11597-11597. DOI: 10.1200/jco.2016.34.15_suppl.11597 |
0.01 |
|
| 2016 |
Sunakawa Y, Wang E, Roberts C, Yang D, Liu Q, Thompson D, Botros I, Moran M, Astrow SH, Hsiang J, Zhang W, Tsuji A, Denda T, Shimada K, Kochi M, et al. Immune-related genes to predict clinical outcome of cetuximab (cet) treatment for metastatic colorectal cancer (mCRC): Immuno-Oncology assay research. Journal of Clinical Oncology. 34: 11591-11591. DOI: 10.1200/JCO.2016.34.15_SUPPL.11591 |
0.01 |
|
| 2016 |
Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Berger MD, West JD, Cremolini C, Lonardi S, Battaglin F, Ning Y, Horiike Y, Yamamoto N, Okazaki S, Miyamoto Y, et al. Genetic variants of Pin1 to predict benefit from irinotecan and oxaliplatin based treatment in patients with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 34: 11589-11589. DOI: 10.1200/jco.2016.34.15_suppl.11589 |
0.01 |
|
| 2016 |
Berger MD, Stintzing S, Heinemann V, Yang D, Sunakawa Y, Ning Y, Matsusaka S, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, West JD, Hanna DL, Barzi A, Zhang W, et al. MKNK1 SNP rs8602 to predict outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial. Journal of Clinical Oncology. 34: 11588-11588. DOI: 10.1200/jco.2016.34.15_suppl.11588 |
0.01 |
|
| 2016 |
Matsusaka S, Ning Y, Yang D, Zhang W, Hanna DL, Cao S, Suenaga M, Okazaki S, Berger MD, Lenz H. Epidermal growth factor receptor mRNA expression in circulating tumor cells as a potential mechanism of molecular escape from regorafenib therapy. Journal of Clinical Oncology. 34: 11517-11517. DOI: 10.1200/jco.2016.34.15_suppl.11517 |
0.01 |
|
| 2016 |
Okazaki S, Loupakis F, Schirripa M, Cao S, Zhang W, Yang D, Ning Y, Berger M, Miyamoto Y, Suenaga M, Gopez R, Borelli B, Cremolini C, Falcone A, Lonardi S, et al. Tandem repeat variation in HIC1 gene predicts outcome for oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Annals of Oncology. 27: vi38. DOI: 10.1093/ANNONC/MDW363.72 |
0.01 |
|
| 2015 |
Kong W, Chen Z, Zhang W, Gong J, Ke J, Xu H. [Correlation of bone mineral density of the mandibular angle, hand and total body in 839 healthy individuals aged from 5 to 18 years]. Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology. 50: 540-3. PMID 26759296 |
0.01 |
|
| 2015 |
Sebio A, Matsusaka S, Zhang W, Yang D, Ning Y, Stremitzer S, Stintzing S, Sunakawa Y, Yamauchi S, Fujimoto Y, Ueno M, Lenz HJ. Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stages II/III colon cancer. The Pharmacogenomics Journal. PMID 26370619 DOI: 10.1038/tpj.2015.64 |
0.01 |
|
| 2015 |
Xie J, Zhou Z, Ma J, Xiang C, Nie Q, Zhang W. Graphics processing unit-based alignment of protein interaction networks. Iet Systems Biology. 9: 120-7. PMID 26243827 DOI: 10.1049/Iet-Syb.2014.0052 |
0.01 |
|
| 2015 |
Ning Y, Hanna DL, Zhang W, Mendez A, Yang D, El-Khoueiry R, Matsusaka S, Sunakawa Y, Stremitzer S, Parekh A, Okazaki S, Berger MD, Barzi A, Lenz HJ. Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach. Molecular Cancer Therapeutics. PMID 26227487 DOI: 10.1158/1535-7163.MCT-15-0359 |
0.01 |
|
| 2015 |
Zhang S, Xie J, Xia Y, Yu S, Gu Z, Feng R, Luo G, Wang D, Wang K, Jiang M, Cheng X, Huang H, Zhang W, Wen T. LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration. Scientific Reports. 5: 12564. PMID 26220523 DOI: 10.1038/srep12564 |
0.01 |
|
| 2015 |
Stintzing S, Zhang W, Heinemann V, Neureiter D, Kemmerling R, Kirchner T, Jung A, Folwaczny M, Yang D, Ning Y, Sebio A, Stremitzer S, Sunakawa Y, Matsusaka S, Yamauchi S, et al. Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer. Molecular Cancer Therapeutics. 14: 2374-81. PMID 26206335 DOI: 10.1158/1535-7163.MCT-15-0121 |
0.01 |
|
| 2015 |
Ding S, Chen G, Zhang W, Xing C, Xu X, Xie H, Lu A, Chen K, Guo H, Ren Z, Zheng S, Zhou L. MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma. Journal of Translational Medicine. 13: 237. PMID 26198300 DOI: 10.1186/s12967-015-0588-8 |
0.01 |
|
| 2015 |
Zhu WM, Song QH, Yan LB, Zhang W, Wu PC, Chin LK, Cai H, Tsai DP, Shen ZX, Deng TW, Ting SK, Gu YD, Lo GQ, Kwong DL, Yang ZC, et al. A Flat Lens with Tunable Phase Gradient by Using Random Access Reconfigurable Metamaterial. Advanced Materials (Deerfield Beach, Fla.). PMID 26184076 DOI: 10.1002/adma.201501943 |
0.01 |
|
| 2015 |
You Q, Wang F, Wu C, Shi T, Min D, Chen H, Zhang W. Synthesis of 1,3,5-triazines via Cu(OAc)2-catalyzed aerobic oxidative coupling of alcohols and amidine hydrochlorides. Organic & Biomolecular Chemistry. 13: 6723-7. PMID 25991063 DOI: 10.1039/c5ob00724k |
0.01 |
|
| 2015 |
Zhang W, Ding ML, Zhang JN, Qiu JR, Shen YH, Ding XY, Deng LF, Zhang WB, Zhu J. mTORC1 maintains the tumorigenicity of SSEA-4(+) high-grade osteosarcoma. Scientific Reports. 5: 9604. PMID 25853231 DOI: 10.1038/srep09604 |
0.01 |
|
| 2015 |
Loupakis F, Yang D, Yau L, Feng S, Cremolini C, Zhang W, Maus MK, Antoniotti C, Langer C, Scherer SJ, Müller T, Hurwitz HI, Saltz L, Falcone A, Lenz HJ. Primary tumor location as a prognostic factor in metastatic colorectal cancer. Journal of the National Cancer Institute. 107. PMID 25713148 DOI: 10.1093/jnci/dju427 |
0.01 |
|
| 2015 |
Stremitzer S, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Sunakawa Y, Yamauchi S, Matsusaka S, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz HJ. Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases. Cancer. 121: 1898-905. PMID 25690670 DOI: 10.1002/cncr.29259 |
0.01 |
|
| 2015 |
Zhang W, Pan D, Wu A, Shen L. Effective and mild method for converting 3β-hydroxysteroids to 3-keto steroids via DDQ/TEMPO. Steroids. 96: 16-20. PMID 25617739 DOI: 10.1016/j.steroids.2015.01.010 |
0.01 |
|
| 2015 |
Bohanes P, Rankin CJ, Blanke CD, Winder T, Ulrich CM, Smalley SR, Rich TA, Martensen JA, Benson AB, Mayer RJ, Cripps CM, Danenberg K, Makar KW, Zhang W, Benedetti JK, et al. Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1583-90. PMID 25589620 DOI: 10.1158/1078-0432.CCR-14-0857 |
0.01 |
|
| 2015 |
Xie J, Ding W, Chen L, Guo Q, Zhang W. Advances in protein contact map prediction based on machine learning. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 11: 265-70. PMID 25548928 |
0.01 |
|
| 2015 |
Bohanes P, Yang D, Loupakis F, Labonte MJ, Gerger A, Ning Y, Lenz C, Lenz F, Wakatsuki T, Zhang W, Benhaim L, El-Khoueiry A, El-Khoueiry R, Lenz HJ. Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer Pharmacogenomics Journal. 15: 226-234. PMID 25487679 DOI: 10.1038/tpj.2014.66 |
0.01 |
|
| 2015 |
Quan WX, Zhu XL, Qiao H, Zhang WF, Tan SP, Zhou DF, Wang XQ. The effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia and the follow-up study. Neuroscience Letters. 584: 197-201. PMID 25449864 DOI: 10.1016/j.neulet.2014.10.029 |
0.01 |
|
| 2015 |
Zhou X, Zhang W, Liu X, Zhang W, Li Y. Interrelationship between diabetes and periodontitis: role of hyperlipidemia. Archives of Oral Biology. 60: 667-74. PMID 25443979 DOI: 10.1016/j.archoralbio.2014.11.008 |
0.01 |
|
| 2015 |
Sebio A, Gerger A, Matsusaka S, Yang D, Zhang W, Stremitzer S, Stintzing S, Sunakawa Y, Yamauchi S, Ning Y, Fujimoto Y, Ueno M, Lenz HJ. Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer. Pharmacogenetics and Genomics. 25: 30-7. PMID 25379721 DOI: 10.1097/FPC.0000000000000101 |
0.01 |
|
| 2015 |
Xiao H, Jiang X, Li D, Wu L, Zhang W, Guo D. Synthesis and luminescence properties of pyrazolone derivatives and their terbium complexes. Luminescence : the Journal of Biological and Chemical Luminescence. 30: 677-85. PMID 25352448 DOI: 10.1002/bio.2804 |
0.01 |
|
| 2015 |
Zhang W, Nan Z, Tian P, Hu M, Gao Z, Li M, Liu G. Microdochium paspali, a new species causing seashore paspalum disease in southern China. Mycologia. 107: 80-9. PMID 25261493 DOI: 10.3852/14-119 |
0.01 |
|
| 2015 |
Zhou X, Liu X, Li J, Aprecio RM, Zhang W, Li Y. Real-time PCR quantification of six periodontal pathogens in saliva samples from healthy young adults. Clinical Oral Investigations. 19: 937-46. PMID 25217278 DOI: 10.1007/s00784-014-1316-0 |
0.01 |
|
| 2015 |
Moreira DM, Oei J, Rawls HR, Wagner J, Chu L, Li Y, Zhang W, Whang K. A novel antimicrobial orthodontic band cement with in situ-generated silver nanoparticles. The Angle Orthodontist. 85: 175-83. PMID 25098188 DOI: 10.2319/022314-127.1 |
0.01 |
|
| 2015 |
Geva R, Vecchione L, Kalogeras KT, Jensen BV, Lenz HJ, Yoshino T, Paez D, Montagut C, Souglakos J, Cappuzzo F, Cervantes A, Frattini M, Fountzilas G, Johansen JS, Høgdall EV, ... Zhang W, et al. FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study. Gut. 64: 921-8. PMID 25011934 DOI: 10.1136/gutjnl-2014-307234 |
0.01 |
|
| 2015 |
Yamauchi S, Okazaki S, Barzi A, Zhang W, Yang D, Cao S, Ning Y, Sunakawa Y, Stremitzer S, Matsusaka S, El-khoueiry R, Mendez A, Parekh A, Lenz H. Association between single nucleotide polymorphisms (SNPs) of genes involved in spindle assembly checkpoint (SAC) and clinical outcomes in advanced gastric cancer (AGC) patients (pts) treated with taxane-based chemotherapy. Journal of Clinical Oncology. 33: 79-79. DOI: 10.1200/jco.2015.33.3_suppl.79 |
0.01 |
|
| 2015 |
Matsusaka S, Loupakis F, Zhang W, Cao S, Yang D, Ning Y, Stremitzer S, Sunakawa Y, Yamauchi S, El-khoueiry R, Parekh A, Mizunuma N, Lenz H. Polymorphism of the chemokine CXCR4 to predict treatment benefit of first-line bevacizumab-based chemotherapy in patients with metastatic colorectal cancer. Journal of Clinical Oncology. 33: 635-635. DOI: 10.1200/jco.2015.33.3_suppl.635 |
0.01 |
|
| 2015 |
Stremitzer S, Stintzing S, Heinemann V, Zhang W, Yang D, Ning Y, Sunakawa Y, Sebio A, Yamauchi S, Matsusaka S, Parekh A, Mendez A, Elkhoueiry R, Lenz H. Variations in Y chromosome-related genes and clinical outcome in metastatic colorectal cancer. Journal of Clinical Oncology. 33: 634-634. DOI: 10.1200/JCO.2015.33.3_SUPPL.634 |
0.01 |
|
| 2015 |
Sunakawa Y, Stintzing S, Heinemann V, Loupakis F, Cremolini C, Cao S, Yang D, Zhang W, Parekh A, Yamauchi S, Ning Y, Stremitzer S, Matsusaka S, Mendez A, El-Khoueiry RE, et al. Macrophage polarization related gene variants to predict clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with bevacizumab (bev) in combination with FOLFIRI. Journal of Clinical Oncology. 33: 621-621. DOI: 10.1200/JCO.2015.33.3_SUPPL.621 |
0.01 |
|
| 2015 |
Sunakawa Y, Ichikawa W, Tsuji A, Moran M, Astrow SH, Yang D, Zhang W, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Takeuchi M, et al. EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type (KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR). Journal of Clinical Oncology. 33: 618-618. DOI: 10.1200/JCO.2015.33.3_SUPPL.618 |
0.01 |
|
| 2015 |
Zhang W, Curtis C, Stintzing S, Heinemann V, Parekh A, Yang D, Cao S, Ning Y, Sunakawa Y, Stremitzer S, Matsusaka S, Okazaki S, El-Khoueiry RE, Mendez A, Barzi A, et al. Profiling of differentially expressed genes in right and left side mCRC patients using nCounter customized gene expression assay. Journal of Clinical Oncology. 33: e14586-e14586. DOI: 10.1200/jco.2015.33.15_suppl.e14586 |
0.01 |
|
| 2015 |
Matsusaka S, Wu AH, Cao S, Mizunuma N, Chin K, Zhang W, Yang D, Ning Y, Stremitzer S, Sunakawa Y, Okazaki S, Parekh A, El-Khoueiry RE, Mendez A, Lenz H. Prognostic impact of Forkhead box-F1 (FOXF1) polymorphisms on the clinical outcome in gastric cancer patients. Journal of Clinical Oncology. 33: 4039-4039. DOI: 10.1200/JCO.2015.33.15_SUPPL.4039 |
0.01 |
|
| 2015 |
Parekh A, Sunakawa Y, Cao S, Matsusaka S, Yang D, Zhang W, Wakatsuki T, Ning Y, Stremitzer S, Mendez A, Okazaki S, Elkhoueiry R, Iqbal S, Barzi A, Azuma M, et al. Estrogen receptor beta (ERβ) gene polymorphisms as a predictor of overall survival in patients with gastric cancer (GC) from Japan and Los Angeles County (LAC). Journal of Clinical Oncology. 33: 4036-4036. DOI: 10.1200/jco.2015.33.15_suppl.4036 |
0.01 |
|
| 2015 |
Benhaim L, Zhang W, Wakatsuki T, Gerger A, Yang D, Paez D, Ning Y, El-Khoueiry RE, Loupakis F, Bohanes PO, Stintzing S, Heinemann V, Lenz H. Genetic variants of kinases suppressors of Ras (KSR) to predict tumor response to first-line cetuximab in patients with mCRC: Prospective analysis in the FIRE 3 trial. Journal of Clinical Oncology. 33: 3613-3613. DOI: 10.1200/JCO.2015.33.15_SUPPL.3613 |
0.01 |
|
| 2015 |
Lenz H, Schumacher F, Loupakis F, Cremolini C, Ning Y, Stremitzer S, Sunakawa Y, Matsusaka S, Okazaki S, Zhang W, Falcone A. Effect of genetic variation on overall survival in a clinical trial of metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 33: 3562-3562. DOI: 10.1200/Jco.2015.33.15_Suppl.3562 |
0.01 |
|
| 2015 |
Parekh A, Ning Y, Stintzing S, Loupakis F, Zhang W, Yang D, Sunakawa Y, Stremitzer S, Matsusaka S, Okazaki S, Elkhoueiry R, Mendez A, Barzi A, Schirripa M, Heinemann V, et al. Genetic variant of TWEAK to predict clinical outcome in mCRC patients (pts) treated with first line FOLFIRI and Bevacizumab (FOLFIRI/BEV) in FIRE-3 and TRIBE cohorts. Journal of Clinical Oncology. 33: 3554-3554. DOI: 10.1200/jco.2015.33.15_suppl.3554 |
0.01 |
|
| 2015 |
Sunakawa Y, Stintzing S, Heinemann V, Cremolini C, Falcone A, Cao S, Yang D, Zhang W, Yamauchi S, Ning Y, Stremitzer S, Matsusaka S, Parekh A, Graver S, Mendez A, et al. Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcome of bevacizumab (bev)-based treatment in patients with metastatic colorectal cancer (mCRC): Results from TRIBE and FIRE3 trials. Journal of Clinical Oncology. 33: 3552-3552. DOI: 10.1200/jco.2015.33.15_suppl.3552 |
0.01 |
|
| 2015 |
Okazaki S, Stintzing S, Heinemann V, Cao S, Zhang W, Yang D, Ning Y, Sunakawa Y, Stremitzer S, Matsusaka S, Elkhoueiry R, Mendez A, Parekh A, Lenz H. TLR6 polymorphism associated with overall survival in metastatic colorectal cancer (mCRC) patients treated with FOLFIRI/bevacizumab enrolled in FIRE3. Journal of Clinical Oncology. 33: 11039-11039. DOI: 10.1200/JCO.2015.33.15_SUPPL.11039 |
0.01 |
|
| 2015 |
Ning Y, Zhang W, Hanna DL, Mendez A, Yang D, Sunakawa Y, Stremitzer S, Matsusaka S, Okazaki S, Parekh A, El-Khoueiry RE, Flores B, Hauch S, Barzi A, El-Khoueiry AB, et al. Circulating tumor cell (CTC) EMT and stem cell biomarker expression predict overall survival (OS) in mCRC by a combined immunomagnetic qRT-PCR approach. Journal of Clinical Oncology. 33: 11018-11018. DOI: 10.1200/JCO.2015.33.15_SUPPL.11018 |
0.01 |
|
| 2015 |
Sebio A, Stintzing S, Heinemann V, Zhang W, Sunakawa Y, Ichikawa W, Tsuji A, Takahashi T, Parekh A, Yang D, Cao S, Ning Y, Stremitzer S, Matsusaka S, Okazak S, et al. 2010 A genetic variant in RASSF1A, a key regulator of HIPPO pathway, predicts survival in two independent cohorts of mCRC patients treated with cetuximab-based chemotherapy European Journal of Cancer. 51: S331. DOI: 10.1016/S0959-8049(16)30935-2 |
0.01 |
|
| 2014 |
Cheng LY, Yu J, Zhang W, Xie SF, Zhou L, Zhang M, Tang SX, Zhang L, Zheng SS. [Risk factors of persistent thrombocytopenia after adult liver transplantation and prophylactic measures]. Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences. 43: 670-7. PMID 25644566 |
0.01 |
|
| 2014 |
Yu J, Xie SF, Xia WL, Cheng LY, Zhang W, Yu SF, Zhang M, Zheng SS. [Risk factors of biliary complications after liver transplantation from donation after cardiac death]. Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences. 43: 664-9. PMID 25644565 |
0.01 |
|
| 2014 |
Lai MC, Zhang W, Yang Z, Zhang W, Owusu-Ansah KG, Yu SF, Geng L, Xie HY, Zhou L, Zheng SS. First case report of isolated penile mucormycosis in a liver transplantation recipient. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 29: 208-10. PMID 25447726 DOI: 10.1016/j.ijid.2014.09.017 |
0.01 |
|
| 2014 |
Li C, Zhang YY, Frieler RA, Zheng XJ, Zhang WC, Sun XN, Yang QZ, Ma SM, Huang B, Berger S, Wang W, Wu Y, Yu Y, Duan SZ, Mortensen RM. Myeloid mineralocorticoid receptor deficiency inhibits aortic constriction-induced cardiac hypertrophy in mice. Plos One. 9: e110950. PMID 25354087 DOI: 10.1371/journal.pone.0110950 |
0.01 |
|
| 2014 |
Sunakawa Y, Wakatsuki T, Yang D, Zhang W, Ning Y, Stintzing S, Stremitzer S, Yamauchi S, Sebio A, El-khoueiry R, Iqbal S, Barzi A, Gerger A, Stotz M, Azuma M, et al. Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients. Pharmacogenetics and Genomics. 24: 588-96. PMID 25203738 DOI: 10.1097/FPC.0000000000000091 |
0.01 |
|
| 2014 |
Wakatsuki T, Stintzing S, Zhang W, Yang D, Azuma M, Ning Y, Yamauchi S, Matsusaka S, Volz NB, Sunakawa Y, Koizumi W, Watanabe M, Barzi A, El Khoueiry AB, Shah MA, et al. Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent. Pharmacogenetics and Genomics. 24: 539-47. PMID 25203737 DOI: 10.1097/FPC.0000000000000087 |
0.01 |
|
| 2014 |
Saridaki Z, Weidhaas JB, Lenz HJ, Laurent-Puig P, Jacobs B, De Schutter J, De Roock W, Salzman DW, Zhang W, Yang D, Pilati C, Bouché O, Piessevaux H, Tejpar S. A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4499-510. PMID 25183481 DOI: 10.1158/1078-0432.CCR-14-0348 |
0.01 |
|
| 2014 |
Zhang W, Zhao CG, Sun HY, Zheng WE, Chen H. Expression characteristics of KAI1 and vascular endothelial growth factor and their diagnostic value for hepatocellular carcinoma. Gut and Liver. 8: 536-42. PMID 25071074 DOI: 10.5009/gnl13331 |
0.01 |
|
| 2014 |
Liu YM, Li BB, Zhang YY, Zhang W, Shen H, Li H, Cao B. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrobial Agents and Chemotherapy. 58: 5379-85. PMID 24982067 DOI: 10.1128/AAC.02523-14 |
0.01 |
|
| 2014 |
Yang H, Aprecio RM, Zhou X, Wang Q, Zhang W, Ding Y, Li Y. Therapeutic effect of TSG-6 engineered iPSC-derived MSCs on experimental periodontitis in rats: a pilot study. Plos One. 9: e100285. PMID 24979372 DOI: 10.1371/journal.pone.0100285 |
0.01 |
|
| 2014 |
Zhang W, Guo F, Wang F, Zhao N, Liu L, Li J, Wang Z. Synthesis of quinazolines via CuO nanoparticles catalyzed aerobic oxidative coupling of aromatic alcohols and amidines. Organic & Biomolecular Chemistry. 12: 5752-6. PMID 24967723 DOI: 10.1039/c4ob00569d |
0.01 |
|
| 2014 |
Zhang W, Chai Y, Li K, Chen Y, Yan D, Guo D. Synthesis and fluorescence properties of 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazol derivatives and their terbium complexes. Luminescence : the Journal of Biological and Chemical Luminescence. 29: 1113-22. PMID 24846775 DOI: 10.1002/bio.2668 |
0.01 |
|
| 2014 |
Omar S, Chen JW, Nelson B, Okumura W, Zhang W. Fluoride concentration in commonly consumed infant juices. Journal of Dentistry For Children (Chicago, Ill.). 81: 20-6. PMID 24709429 |
0.01 |
|
| 2014 |
Wang M, Zhang W, Ding W, Dai D, Zhang H, Xie H, Chen L, Guo Y, Xie J. Parallel clustering algorithm for large-scale biological data sets. Plos One. 9: e91315. PMID 24705246 DOI: 10.1371/Journal.Pone.0091315 |
0.01 |
|
| 2014 |
Yu J, Zhang W, Gao F, Liu YX, Chen ZY, Cheng LY, Xie SF, Zheng SS. FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 13: 184-91. PMID 24686546 DOI: 10.1016/S1499-3872(14)60029-1 |
0.01 |
|
| 2014 |
Yu S, Guo H, Zhang W, Yu J, Yan S, Wu J, Zhang M, Zheng S. Orthotopic liver transplantation in situs inversus adult from an ABO-incompatible donor with situs inversus. Bmc Gastroenterology. 14: 46. PMID 24625305 DOI: 10.1186/1471-230X-14-46 |
0.01 |
|
| 2014 |
Sebio A, Stintzing S, Stremitzer S, Zhang W, Lenz HJ. Panitumumab : leading to better overall survival in metastatic colorectal cancer? Expert Opinion On Biological Therapy. 14: 535-48. PMID 24593265 DOI: 10.1517/14712598.2014.894502 |
0.01 |
|
| 2014 |
Xu J, Wang YY, Dai YJ, Zhang W, Zhang WN, Xiong SM, Gu ZH, Wang KK, Zeng R, Chen Z, Chen SJ. DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America. 111: 2620-5. PMID 24497509 DOI: 10.1073/pnas.1400150111 |
0.01 |
|
| 2014 |
Li XY, Jiang LJ, Chen L, Ding ML, Guo HZ, Zhang W, Zhang HX, Ma XD, Liu XZ, Xi XD, Chen SJ, Chen Z, Zhu J. RIG-I modulates Src-mediated AKT activation to restrain leukemic stemness. Molecular Cell. 53: 407-19. PMID 24412064 DOI: 10.1016/j.molcel.2013.12.008 |
0.01 |
|
| 2014 |
Tian N, Wang YD, Philippe M, Zhang W, Jiang ZK, Li LQ. A specialized new species of Ashicaulis (Osmundaceae, Filicales) from the Jurassic of Liaoning, NE China. Journal of Plant Research. 127: 209-19. PMID 24317753 DOI: 10.1007/s10265-013-0611-1 |
0.01 |
|
| 2014 |
Ning Y, Gerger A, Zhang W, Hanna DL, Yang D, Winder T, Wakatsuki T, Labonte MJ, Stintzing S, Volz N, Sunakawa Y, Stremitzer S, El-Khoueiry R, Lenz HJ. Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy. Molecular Cancer Therapeutics. 13: 528-39. PMID 24170770 DOI: 10.1158/1535-7163.MCT-13-0646 |
0.01 |
|
| 2014 |
Sunakawa Y, Wakatsuki T, Zhang W, Yang D, Azuma M, Ning Y, Stintzing S, Stremitzer S, Yamauchi S, Sebio A, Volz NB, El-khoueiry R, Koizumi W, Watanabe M, Lenz H. Use of genetic variants in c-MET to predict clinical outcome in localized gastric cancer (GC) patients (pts) treated with surgery. Journal of Clinical Oncology. 32: 50-50. DOI: 10.1200/JCO.2014.32.3_SUPPL.50 |
0.01 |
|
| 2014 |
Stremitzer S, Berghoff AS, Volz NB, Zhang W, Yang D, Stintzing S, Ning Y, Sunakawa Y, Yamauchi S, Sebio A, El-Khoueiry RE, Birner P, Preusser M, Lenz H. Influence of genetic variants of genes potentially associated with colorectal brain metastases on overall survival. Journal of Clinical Oncology. 32: 487-487. DOI: 10.1200/jco.2014.32.3_suppl.487 |
0.01 |
|
| 2014 |
Matsusaka S, Loupakis F, Zhang W, Yang D, Ning Y, Stintzing S, Sunakawa Y, Yamauchi S, Stremitzer S, Sebio A, El-Khoueiry RE, Pasquini G, Marmorino F, Schirripa M, Inoshita N, et al. Association of the prognostic role of CXCR4/CXCL12 polymorphism with treatment outcomes after bevacizumab-based chemotherapy in metastatic colorectal cancer. Journal of Clinical Oncology. 32: e22008-e22008. DOI: 10.1200/JCO.2014.32.15_SUPPL.E22008 |
0.01 |
|
| 2014 |
Siamak S, Sunakawa Y, Loupakis F, Yang D, Zhang W, Ning Y, Stintzing S, Stremitzer S, Sebio A, Yamauchi S, Matsusaka S, El-Khoueiry RE, Antoniotti C, Rossini D, Cremolini C, et al. CCL2 polymorphism as a predictive marker for bevacizumab (Bev) in combination with FOLFIRI as first-line treatment in metastatic colorectal cancer (mCRC) patients (pts). Journal of Clinical Oncology. 32: e14556-e14556. DOI: 10.1200/jco.2014.32.15_suppl.e14556 |
0.01 |
|
| 2014 |
Garcia AS, Marmorino F, Gerger A, Zhang W, Yang D, Ning Y, Stintzing S, Stremitzer S, Sunakawa Y, Yamauchi S, Matsusaka S, Salvatore L, Cremolini C, El-Khoueiry RE, Falcone A, et al. Genetic variant in the down syndrome candidate region 1 (DSCR1) gene: A novel biomarker in metastatic colorectal cancer. Journal of Clinical Oncology. 32: e14544-e14544. DOI: 10.1200/JCO.2014.32.15_SUPPL.E14544 |
0.01 |
|
| 2014 |
Ning Y, Zhang W, Yang D, Stintzing S, Sunakawa Y, Stremitzer S, Sebio A, Yamauchi S, Matsusaka S, Zoratto F, Loupakis F, El-Khoueiry RE, Barzi A, El-Khoueiry AB, Kahn M, et al. Genetic variants of CBP and SOX9 to predict clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI and bevacizumab (FOLFIRI/BEV). Journal of Clinical Oncology. 32: e14528-e14528. DOI: 10.1200/jco.2014.32.15_suppl.e14528 |
0.01 |
|
| 2014 |
Hanna DL, Garcia AS, Zhang W, Yang D, Loupakis F, Stintzing S, Stremitzer S, Ning Y, Sunakawa Y, Yamauchi S, Matsusaka S, Cremolini C, El-Khoueiry RE, Falcone A, Lenz H. Common genetic variants in genes involved in the Hippo pathway: Novel biomarkers in metastatic colorectal cancer patients treated with irinotecan plus cetuximab. Journal of Clinical Oncology. 32: e14523-e14523. DOI: 10.1200/jco.2014.32.15_suppl.e14523 |
0.01 |
|
| 2014 |
Yang D, Stremitzer S, Zhang W, Ning Y, Stintzing S, Sebio A, Sunakawa Y, Yamauchi S, Matsusaka S, El-Khoueiry RE, Stift J, Wrba F, Gruenberger T, Lenz H. Association of outcome with genes involved in tumor dormancy in patients with resected colorectal liver metastases. Journal of Clinical Oncology. 32: e14512-e14512. DOI: 10.1200/JCO.2014.32.15_SUPPL.E14512 |
0.01 |
|
| 2014 |
Yamauchi S, Loupakis F, Matsusaka S, Zhang W, Yang D, Ning Y, Stintzing S, Sunakawa Y, Stremitzer S, Sebio A, El-Khoueiry RE, Pasquini G, Marmorino F, Schirripa M, Fujimoto Y, et al. Association of single nucleotide polymorphisms in genes involved in autophagy with overall survival in patients with metastatic colorectal cancer. Journal of Clinical Oncology. 32: e14506-e14506. DOI: 10.1200/JCO.2014.32.15_SUPPL.E14506 |
0.01 |
|
| 2014 |
Garcia AS, Zhang W, Yang D, Stremitzer S, Stintzing S, Ning Y, Sunakawa Y, Yamauchi S, Matsusaka S, El-Khoueiry RE, Barzi A, Iqbal S, El-Khoueiry AB, Lenz H. Germline polymorphisms in genes involved in the Hippo pathway to predict recurrence in locally advanced colon cancer. Journal of Clinical Oncology. 32: e14505-e14505. DOI: 10.1200/JCO.2014.32.15_SUPPL.E14505 |
0.01 |
|
| 2014 |
Sunakawa Y, Zhang W, Yang D, Wakatsuki T, Ning Y, Stintzing S, Stremitzer S, Sebio A, Yamauchi S, Matsusaka S, El-Khoueiry RE, Iqbal S, Barzi A, Azuma M, Watanabe M, et al. Association of polymorphisms in the CCL2/CCR2 axis with clinical outcome in localized advanced gastric cancer (AGC) patients (pts) from the United States and Japan. Journal of Clinical Oncology. 32: 4052-4052. DOI: 10.1200/jco.2014.32.15_suppl.4052 |
0.01 |
|
| 2014 |
Sunakawa Y, Volz NB, Zhang W, Yang D, Wakatsuki T, Ning Y, Stintzing S, Stremitzer S, Sebio A, Yamauchi S, Matsusaka S, El-Khoueiry RE, Iqbal S, Barzi A, Azuma M, et al. Genetic variants in tumor immune checkpoints as prognostic markers in patients (pts) with localized advanced gastric cancer (AGC). Journal of Clinical Oncology. 32: 4018-4018. DOI: 10.1200/JCO.2014.32.15_SUPPL.4018 |
0.01 |
|
| 2014 |
Zhang W, Schumacher F, Loupakis F, van Den Berg D, Cremolini C, Stintzing S, Ning Y, Sebio A, Stremitzer S, Sunakawa Y, Matsusaka S, Yamauchi S, Elkhoueiry R, Falcone A, Lenz H. High-throughput exome array for identification of novel polymorphisms associated with clinical outcome in mCRC patients treated with first-line FOLFOXIRI/BEV versus FOLFIRI/BEV (TRIBE trial; NCT00719797). Journal of Clinical Oncology. 32: 3632-3632. DOI: 10.1200/Jco.2014.32.15_Suppl.3632 |
0.01 |
|
| 2014 |
Ning Y, Stintzing S, Heinemann V, Zhang W, Yang D, Sunakawa Y, Stremitzer S, Sebio A, Yamauchi S, Matsusaka S, Elkhoueiry R, Barzi A, El-Khoueiry AB, Lenz H. Genetic variants of TCF7L2 and AXIN2 predict gender and tumor location-dependent clinical outcome in FIRE-3 trial: A validation study. Journal of Clinical Oncology. 32: 3602-3602. DOI: 10.1200/jco.2014.32.15_suppl.3602 |
0.01 |
|
| 2014 |
Stintzing S, Stremitzer S, Heinemann V, Falcone A, Loupakis F, Cremolini C, Antoniotti C, Sunakawa Y, Matsusaka S, Yamauchi S, Zhang W, Yang D, Ning Y, Sebio A, Hanna DL, et al. Biomarker validation study: Genes involved in ubiquitin proteasome system (UPS) dependent EGFR-degradation for prediction of efficacy in metastatic colorectal cancer patients treated with cetuximab. Journal of Clinical Oncology. 32: 3571-3571. DOI: 10.1200/JCO.2014.32.15_SUPPL.3571 |
0.01 |
|
| 2014 |
Preusser M, Stremitzer S, Berghoff AS, Volz NB, Zhang W, Yang D, Stintzing S, Ning Y, Sunakawa Y, Yamauchi S, Sebio A, Matsusaka S, El-Khoueiry RE, Birner P, Lenz H. Influence of genetic variants of genes potentially associated with brain metastases on overall survival in 70 colorectal cancer patients. Journal of Clinical Oncology. 32: 3565-3565. DOI: 10.1200/JCO.2014.32.15_SUPPL.3565 |
0.01 |
|
| 2014 |
Stremitzer S, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Sunakawa Y, Yamauchi S, Matsusaka S, El-Khoueiry RE, Stift J, Wrba F, Gruenberger T, Lenz H. Influence of genetic variations of the angiopoietin and pericyte pathways in resected colorectal liver metastases. Journal of Clinical Oncology. 32: 3564-3564. DOI: 10.1200/JCO.2014.32.15_SUPPL.3564 |
0.01 |
|
| 2014 |
Stremitzer S, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Sunakawa Y, Yamauchi S, Matsusaka S, El-Khoueiry RE, Stift J, Wrba F, Gruenberger T, Lenz H. Association outcome with genes involved in immune response and checkpoints in patients with resected colorectal liver metastases. Journal of Clinical Oncology. 32: 3563-3563. DOI: 10.1200/JCO.2014.32.15_SUPPL.3563 |
0.01 |
|
| 2014 |
Stintzing S, Stremitzer S, Heinemann V, Jung A, Sunakawa Y, Matsusaka S, Yamauchi S, Zhang W, Yang D, Ning Y, Sebio A, Hanna DL, Siamak S, Lenz H. Amphiregulin (AREG) SNP rs161511 to predict cetuximab efficacy independent of AREG mRNA levels: Data from FIRE3 (AIO KRK-0306). Journal of Clinical Oncology. 32: 3521-3521. DOI: 10.1200/JCO.2014.32.15_SUPPL.3521 |
0.01 |
|
| 2013 |
Wang XQ, Ng RK, Ming X, Zhang W, Chen L, Chu AC, Pang R, Lo CM, Tsao SW, Liu X, Poon RT, Fan ST. Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines. Plos One. 8: e72435. PMID 24023739 DOI: 10.1371/Journal.Pone.0072435 |
0.01 |
|
| 2013 |
Xiao F, Zhang W, Zhou L, Xie H, Xing C, Ding S, Chen K, Zheng S. microRNA-200a is an independent prognostic factor of hepatocellular carcinoma and induces cell cycle arrest by targeting CDK6. Oncology Reports. 30: 2203-10. PMID 24009066 DOI: 10.3892/or.2013.2715 |
0.01 |
|
| 2013 |
Xiao F, Zhang W, Chen L, Chen F, Xie H, Xing C, Yu X, Ding S, Chen K, Guo H, Cheng J, Zheng S, Zhou L. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. Journal of Translational Medicine. 11: 195. PMID 23967867 DOI: 10.1186/1479-5876-11-195 |
0.01 |
|
| 2013 |
Wakatsuki T, LaBonte MJ, Bohanes PO, Zhang W, Yang D, Azuma M, Barzi A, Ning Y, Loupakis F, Saadat S, Volz N, Stintzing S, El-Khoueiry R, Koizumi W, Watanabe M, et al. Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States. Molecular Cancer Therapeutics. 12: 2261-72. PMID 23918832 DOI: 10.1158/1535-7163.MCT-12-1134 |
0.01 |
|
| 2013 |
Yang JH, Li ZC, Kong WD, Zhang W, Jia YP, Zhang YL, Liu LB, Han XP. Effect of orthodontic force on inflammatory periodontal tissue remodeling and expression of IL-6 and IL-8 in rats. Asian Pacific Journal of Tropical Medicine. 6: 757-61. PMID 23870461 DOI: 10.1016/S1995-7645(13)60133-9 |
0.01 |
|
| 2013 |
Loupakis F, Cremolini C, Yang D, Salvatore L, Zhang W, Wakatsuki T, Bohanes P, Schirripa M, Benhaim L, Lonardi S, Antoniotti C, Aprile G, Graziano F, Ruzzo A, Lucchesi S, et al. Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab. Plos One. 8: e66774. PMID 23861747 DOI: 10.1371/journal.pone.0066774 |
0.01 |
|
| 2013 |
Yu J, Yin S, Zhang W, Gao F, Liu Y, Chen Z, Zhang M, He J, Zheng S. Hypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model. Stem Cell Research & Therapy. 4: 83. PMID 23856418 DOI: 10.1186/scrt234 |
0.01 |
|
| 2013 |
Wang Q, Zhang W, Li H, Aprecio R, Wu W, Lin Y, Li Y. Effects of 25-hydroxyvitamin D3 on cathelicidin production and antibacterial function of human oral keratinocytes. Cellular Immunology. 283: 45-50. PMID 23850962 DOI: 10.1016/j.cellimm.2013.06.007 |
0.01 |
|
| 2013 |
Ding S, Zhang W, Xu Z, Xing C, Xie H, Guo H, Chen K, Song P, Gu Y, Xiao F, Zhou L, Zheng S. Induction of an EMT-like transformation and MET in vitro. Journal of Translational Medicine. 11: 164. PMID 23829659 DOI: 10.1186/1479-5876-11-164 |
0.01 |
|
| 2013 |
Xu R, Mortimer PE, Kuang RP, He J, Zhang WD, Yin F. Sublethal impact of paraquat on the life span and parasitic behavior of Diaeretiella rapae M'Intosh. Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes. 48: 651-7. PMID 23638892 DOI: 10.1080/03601234.2013.778597 |
0.01 |
|
| 2013 |
Ding W, Xie J, Dai D, Zhang H, Xie H, Zhang W. CNNcon: improved protein contact maps prediction using cascaded neural networks. Plos One. 8: e61533. PMID 23626696 DOI: 10.1371/journal.pone.0061533 |
0.01 |
|
| 2013 |
Liu B, Liu Q, Xiao H, Zhang W, Tao R. Family of dumbbell Ni4Ln2 (Ln = Pr, Sm, Eu, Gd, Tb, Ho, Er) complexes: syntheses, structures, luminescent and magnetic properties. Dalton Transactions (Cambridge, England : 2003). 42: 5047-55. PMID 23396382 DOI: 10.1039/c3dt32935f |
0.01 |
|
| 2013 |
Ding C, Zhang W, Li J, Lei J, Yu J. Cytotoxic constituents of ethyl acetate fraction from Dianthus superbus. Natural Product Research. 27: 1691-4. PMID 23351147 DOI: 10.1080/14786419.2012.763127 |
0.01 |
|
| 2013 |
Xing C, Zhou W, Ding S, Xie H, Zhang W, Yang Z, Wei B, Chen K, Su R, Cheng J, Zheng S, Zhou L. Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma. Molecular Cancer Therapeutics. 12: 94-103. PMID 23136185 DOI: 10.1158/1535-7163.MCT-12-0672 |
0.01 |
|
| 2013 |
Pohl A, El-Khoueiry A, Yang D, Zhang W, Lurje G, Ning Y, Winder T, Hu-Lieskoven S, Iqbal S, Danenberg KD, Kahn M, Teo JL, Shriki J, Stebbing J, Lenz HJ. Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy Pharmacogenomics Journal. 13: 173-180. PMID 22231565 DOI: 10.1038/tpj.2011.61 |
0.01 |
|
| 2013 |
Wakatsuki T, Páez D, Zhang W, Labonte MJ, Yang D, Azuma M, Ning Y, Volz N, Stintzing S, Bohanes PO, El-Khoueiry R, Koizumi W, Watanabe M, Lenz H. Association between genetic variations involved in tumor dormancy related genes and clinical outcomes in Japanese patients with gastric cancer. Journal of Clinical Oncology. 31: 43-43. DOI: 10.1200/JCO.2013.31.4_SUPPL.43 |
0.01 |
|
| 2013 |
Benhaim L, Gerger A, Bohanes PO, Paez D, Wakatsuki T, Yang D, Labonte MJ, Zhang W, Ning Y, Loupakis F, El-Khoueiry R, Laurent-Puig P, Lenz H. Gender specific profiling in SCN1A polymorphisms and time to recurrence in patients with stage II/III colorectal cancer. Journal of Clinical Oncology. 31: 393-393. DOI: 10.1200/JCO.2013.31.4_SUPPL.393 |
0.01 |
|
| 2013 |
Wakatsuki T, Zhang W, Yang D, Azuma M, Ning Y, Volz NB, Stintzing S, El-Khoueiry RE, Li JE, Wilson PMD, Labonte MJ, Maus MKH, Sunakawa Y, Koizumi W, Watanabe M, et al. Association of AREG exon 1 polymorphism with worse prognosis in Japanese and U.S. patients with gastric cancer. Journal of Clinical Oncology. 31: e15022-e15022. DOI: 10.1200/jco.2013.31.15_suppl.e15022 |
0.01 |
|
| 2013 |
Iqbal S, Wakatsuki T, Bohanes PO, Zhang W, Gerger A, Azuma M, Stotz M, Yang D, Ning Y, Volz NB, Stintzing S, El-Khoueiry RE, Labonte MJ, Li JE, Maus MKH, et al. Iiteglinα4 (ITGα4) rs7562325 polymorphism was associated with better survivals in Austrian but not in Japanese patients with gastric cancer. Journal of Clinical Oncology. 31: e15009-e15009. DOI: 10.1200/jco.2013.31.15_suppl.e15009 |
0.01 |
|
| 2013 |
Zhang W, Ning Y, Yang D, Wakatsuki T, Stintzing S, Volz NB, Li JE, Labonte MJ, El-Khoueiry RE, Barzi A, El-Khoueiry AB, Kahn M, Lenz H. Prediction of tumor recurrence by tumor location in stage II and III colon cancer patients through common germ-line variants of genes involved in wnt signaling pathway. Journal of Clinical Oncology. 31: e14714-e14714. DOI: 10.1200/jco.2013.31.15_suppl.e14714 |
0.01 |
|
| 2013 |
Wilson PMD, Wakatsuki T, Loupakis F, Zhang W, Yang D, Stintzing S, Ning Y, Volz NB, El-Khoueiry RE, Li JE, Labonte MJ, Sunakawa Y, Maus MKH, Ladner RD, Barzi A, et al. Association of a polymorphism in amphiregulin with worse prognosis in metastatic colorectal cancer patients treated with cetuximab. Journal of Clinical Oncology. 31: e14543-e14543. DOI: 10.1200/Jco.2013.31.15_Suppl.E14543 |
0.01 |
|
| 2013 |
Ladner RD, Kahn M, Yang D, Stintzing S, Zhang W, Wakatsuki T, Ning Y, Volz NB, Li JE, Labonte MJ, Wilson PMD, Kardosh A, Lenz H. Risk of tumor-related death in stage I-III colon cance based on gender and tumor location. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E14538 |
0.01 |
|
| 2013 |
El-Khoueiry RE, Wakatsuki T, Ning Y, Zhang W, Yang D, Azuma M, Gerger A, Stotz M, Labonte MJ, Wilson PMD, Volz NB, Stintzing S, Maus MKH, Sunakawa Y, Koizumi W, et al. Association of transcription factor 7-like 2 (TCF7L2) polymorphisms with worse survival in three independent cohorts from the United States, Austria, and Japan in patients with gastric cancer. Journal of Clinical Oncology. 31: 4111-4111. DOI: 10.1200/jco.2013.31.15_suppl.4111 |
0.01 |
|
| 2013 |
Labonte MJ, Wakatsuki T, Zhang W, Yang D, Azuma M, Gerger A, Stotz M, Ning Y, Volz NB, Stintzing S, Li JE, El-Khoueiry RE, Wilson PMD, Koizumi W, Watanabe M, et al. Prognostic outcome of gastric cancer patients with cancer stem cell SNPs in Asian versus western countries. Journal of Clinical Oncology. 31: 4110-4110. DOI: 10.1200/jco.2013.31.15_suppl.4110 |
0.01 |
|
| 2013 |
Ning Y, Zhang W, Yang D, Loupakis F, Wakatsuki T, Stintzing S, Volz NB, Li JE, El-Khoueiry RE, Labonte MJ, Cremolini C, Marmorino F, Barzi A, El-Khoueiry AB, Lenz H, et al. Use of genetic variants in wnt signaling pathway to predict gender and tumor location dependent survival in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI and bevacizumab (BEV). Journal of Clinical Oncology. 31: 3568-3568. DOI: 10.1200/jco.2013.31.15_suppl.3568 |
0.01 |
|
| 2013 |
Schultheis AM, Volz NB, Zhang W, Yang D, Ning Y, Stintzing S, Wakatsuki T, El-Khoueiry RE, Li JE, Kardosh A, Barzi A, El-Khoueiry AB, Lenz H. Use of genetic variants in immune response genes to predict clinical outcome in mCRC patients treated with cetuximab-based therapy. Journal of Clinical Oncology. 31: 3567-3567. DOI: 10.1200/Jco.2013.31.15_Suppl.3567 |
0.01 |
|
| 2013 |
Volz NB, Zhang W, Yang D, Ning Y, Stintzing S, Wakatsuki T, El-Khoueiry RE, Li JE, Kardosh A, Loupakis F, Marmorino F, Antoniotti C, Lenz H. Use of genetic variants in pericyte-driven tumor vessel maturation genes to predict treatment efficacy in mCRC patients treated with FOLFIRI/bevacizumab. Journal of Clinical Oncology. 31: 3566-3566. DOI: 10.1200/Jco.2013.31.15_Suppl.3566 |
0.01 |
|
| 2013 |
Li JE, Zhang W, Loupakis F, Yang D, Wakatsuki T, Ning Y, Stintzing S, El-Khoueiry RE, Volz NB, Marmorino F, Schirripa M, Salvatore L, Antoniotti C, Cremolini C, Lenz H. EGFL7 polymorphism to predict tumor response in metastatic colorectal cancer (mCRC) patients (pts) treated with FOLFIRI and bevacizumab (BV). Journal of Clinical Oncology. 31: 3565-3565. DOI: 10.1200/JCO.2013.31.15_SUPPL.3565 |
0.01 |
|
| 2013 |
Stintzing S, Zhang W, Wakatsuki T, Ning Y, Volz NB, Li JE, Labonte MJ, Wilson PMD, Kardosh A, Loupakis F, Salvatore L, Schirripa M, Lenz H. Genes involved in EGFR-degradation to predict for efficacy in metastatic colorectal cancer patients treated with cetuximab. Journal of Clinical Oncology. 31: 3557-3557. DOI: 10.1200/Jco.2013.31.15_Suppl.3557 |
0.01 |
|
| 2012 |
Zhang W, Gerger A, Labonte MJ, Yang D, Bohanes PO, Ning Y, Winder T, Wilson PM, Benhaim L, El-Khoueiry R, El-Khoueiry AB, Iqbal S, Giamas G, Stebbing J, Lenz HJ. Association of gender-related tumor recurrence with a polymorphic variant of LMTK3 in stage II and III colon cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 454. PMID 27983209 DOI: 10.1200/jco.2012.30.4_suppl.454 |
0.01 |
|
| 2012 |
Labonte MJ, Goldman BH, Zhang W, Blanke CD, Philip PA, Wong R, O'Reilly EM, Benedetti JK, Lenz HJ. Use of EGF A61G polymorphism to predict overall survival in a phase III study of gemcitabine plus cetuximab versus gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma (SWOG 0205). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 203. PMID 27983172 DOI: 10.1200/jco.2012.30.4_suppl.203 |
0.01 |
|
| 2012 |
Loupakis F, Zhang W, Gerger A, Yang D, Bohanes PO, Labonte MJ, Benhaim L, Wakatsuki T, Ning Y, Wilson PM, El-Khoueiry R, El-Khoueiry AB, Iqbal S, Barzi A, Giamas G, et al. LMTK3 polymorphism in patients with metastatic colon cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 471. PMID 27983134 DOI: 10.1200/jco.2012.30.4_suppl.471 |
0.01 |
|
| 2012 |
Wakatsuki T, Bohanes PO, Zhang W, Gerger A, Yang D, Ning Y, Winder T, Labonte MJ, Wilson PM, Benhaim L, El-Khoueiry R, El-Khoueiry AB, Iqbal S, Giamas G, Stebbing J, et al. Use of genetic variants of LMTK3 to predict tumor recurrence in female localized gastric adenocarcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 63. PMID 27982860 DOI: 10.1200/jco.2012.30.4_suppl.63 |
0.01 |
|
| 2012 |
Xie J, Wang M, Dai D, Zhang H, Zhang W. A network clustering algorithm for detection of protein families. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2012: 6329-32. PMID 23367376 DOI: 10.1109/EMBC.2012.6347441 |
0.01 |
|
| 2012 |
Wang YH, Hu B, Wang YS, Liu W, Zhang W. [Characteristics of atmospheric pollutants in Cangzhou]. Huan Jing Ke Xue= Huanjing Kexue / [Bian Ji, Zhongguo Ke Xue Yuan Huan Jing Ke Xue Wei Yuan Hui "Huan Jing Ke Xue" Bian Ji Wei Yuan Hui.]. 33: 3705-11. PMID 23323396 |
0.01 |
|
| 2012 |
Tu ZH, Shang DS, Jiang JC, Zhang W, Zhang M, Wang WL, Lou HY, Zheng SS. Liver transplantation in Crigler-Najjar syndrome type I disease. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 11: 545-8. PMID 23060403 DOI: 10.1016/S1499-3872(12)60222-7 |
0.01 |
|
| 2012 |
Xu ZY, Ding SM, Zhou L, Xie HY, Chen KJ, Zhang W, Xing CY, Guo HJ, Zheng SS. FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition. International Journal of Biological Sciences. 8: 1130-41. PMID 22991501 DOI: 10.7150/ijbs.4769 |
0.01 |
|
| 2012 |
Zheng WE, Chen H, Yuan SF, Wu LL, Zhang W, Sun HY, Chen WJ. Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer. Journal of B.U.On. : Official Journal of the Balkan Union of Oncology. 17: 284-90. PMID 22740207 |
0.01 |
|
| 2012 |
Sun H, Yang J, Kawashima N, Li Y, Zhang W, Wang P. A brief comparison of curricula at dental schools in China and Japan. Journal of Dental Education. 76: 765-73. PMID 22659706 |
0.01 |
|
| 2012 |
Bohanes P, Yang D, Chhibar RS, Labonte MJ, Winder T, Ning Y, Gerger A, Benhaim L, Paez D, Wakatsuki T, Loupakis F, El-Khoueiry R, Zhang W, Lenz HJ. Influence of sex on the survival of patients with esophageal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2265-72. PMID 22585694 DOI: 10.1200/JCO.2011.38.8751 |
0.01 |
|
| 2012 |
Wang XQ, Lo CM, Chen L, Cheung CK, Yang ZF, Chen YX, Ng MN, Yu WC, Ming X, Zhang W, Ho DW, Chan SC, Fan ST. Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver. Hepatology (Baltimore, Md.). 56: 1557-66. PMID 22544823 DOI: 10.1002/hep.25820 |
0.01 |
|
| 2012 |
Yuan SF, Zhu LJ, Zheng WE, Chen H, Wu LL, Zhang W, Sun HY, Chen WJ. Expression of β-tubulin III and survivin in advance stage breast cancer correlates with chemotherapeutic effects of docetaxel. Asian Pacific Journal of Cancer Prevention : Apjcp. 13: 361-5. PMID 22502701 DOI: 10.7314/APJCP.2012.13.1.361 |
0.01 |
|
| 2012 |
Lu H, Zhu S, Qian L, Xiang D, Zhang W, Nie A, Gao J, Wu M, Gao J, Lu B, Yu Y, Han W, Moldenhauer A. Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicity. Blood. 119: 4868-77. PMID 22474250 DOI: 10.1182/blood-2011-07-367581 |
0.01 |
|
| 2012 |
Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D, Benhaim L, Paez D, Rosenberg DO, Nagulapalli Venkata KC, Louie SG, Petasis NA, Ladner RD, Lenz HJ. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Molecular Cancer Therapeutics. 11: 1353-64. PMID 22391039 DOI: 10.1158/1535-7163.Mct-11-0915 |
0.01 |
|
| 2012 |
Xing C, Xie H, Zhou L, Zhou W, Zhang W, Ding S, Wei B, Yu X, Su R, Zheng S. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation. Biochemical and Biophysical Research Communications. 420: 29-35. PMID 22390936 DOI: 10.1016/j.bbrc.2012.02.107 |
0.01 |
|
| 2012 |
Zhang XY, Zhou DF, Shen YC, Zhang PY, Zhang WF, Liang J, Chen da C, Xiu MH, Kosten TA, Kosten TR. Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia. Neuropharmacology. 62: 1928-34. PMID 22227558 DOI: 10.1016/J.Neuropharm.2011.12.014 |
0.01 |
|
| 2012 |
Páez D, Labonte MJ, Bohanes P, Zhang W, Benhanim L, Ning Y, Wakatsuki T, Loupakis F, Lenz HJ. Cancer dormancy: a model of early dissemination and late cancer recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 645-53. PMID 22156560 DOI: 10.1158/1078-0432.CCR-11-2186 |
0.01 |
|
| 2012 |
Chen WJ, Yuan SF, Yan QY, Xiong JP, Wang SM, Zheng WE, Zhang W, Sun HY, Chen H, Wu LL. Intrapleural chemo- and hyperthermotherapies for malignant pleural effusion: a randomized prospective study. Cancer Investigation. 30: 126-30. PMID 22148972 DOI: 10.3109/07357907.2011.633292 |
0.01 |
|
| 2012 |
Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu X, Sun J, Yang S, Poon RT, Fan ST. Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma. International Journal of Cancer. Journal International Du Cancer. 131: E163-72. PMID 22052196 DOI: 10.1002/ijc.27336 |
0.01 |
|
| 2012 |
Páez D, Labonte MJ, Paré L, Yang D, Bohanes PO, Gerger A, Zhang W, Benhaim L, Ning Y, Wakatsuki T, Loupakis F, Lenz H. Use of leucine-rich and immunoglobulin-like domains germ-line polymorphisms to predict clinical outcome in metastatic colorectal cancer. Journal of Clinical Oncology. 30: e14052-e14052. DOI: 10.1200/JCO.2012.30.15_SUPPL.E14052 |
0.01 |
|
| 2012 |
Wilson PM, Páez D, Gerger A, Zhang W, Yang D, Labonte MJ, Benhaim L, Bohanes PO, Ning Y, Wakatsuki T, Loupakis F, Lenz H. Use of germ-line variants in the WNT/β-CATENIN pathway to predict tumor recurrence in adjuvant colon cancer. Journal of Clinical Oncology. 30: e14034-e14034. DOI: 10.1200/JCO.2012.30.15_SUPPL.E14034 |
0.01 |
|
| 2012 |
Ning Y, Winder T, Zhang W, Yang D, Loupakis F, Wakatsuki T, Bohanes PO, EI-Khoueiry R, Barzi A, Iqbal S, EI-Khoueiry A, Lenz H. Association of genetic variants in plastin family genes with tumor recurrence in stage II/III colon cancer. Journal of Clinical Oncology. 30: e14031-e14031. DOI: 10.1200/jco.2012.30.15_suppl.e14031 |
0.01 |
|
| 2012 |
Zhang W, Benhaim L, Yang D, Gerger A, Bohanes PO, Páez D, Loupakis F, Wakatsuki T, Labonte MJ, Ning Y, El-Khoueiry R, Zhang H, Stebbing J, Giamas G, Lenz H. Genetic variants of kinases suppressors of ras (KSR1) to predict survival in patients with ER-alpha positive metastatic breast cancer. Journal of Clinical Oncology. 30: e11018-e11018. DOI: 10.1200/JCO.2012.30.15_SUPPL.E11018 |
0.01 |
|
| 2012 |
Iqbal S, El-Khoueiry AB, Yang D, Páez D, Duddalwar V, Zhang W, Agafitei RD, Lujan R, Cole S, Ning Y, El-Khoueiry R, Loupakis F, Wakatsuki T, Lenz H. A phase II study of capecitabine-oxaliplatin and cetuximab in patients (pts) with advanced/metastatic gastric cancer (G) or gastroesophageal junction (GEJ) adenocarcinoma. Journal of Clinical Oncology. 30: 4096-4096. DOI: 10.1200/JCO.2012.30.15_SUPPL.4096 |
0.01 |
|
| 2012 |
Barzi A, Wakatsuki T, Zhang W, Yang D, Loupakis F, Ning Y, El-Khoueiry R, Labonte MJ, Azuma M, Bohanes PO, Benhaim L, Gerger A, Koizumi W, Watanabe M, Stebbing J, et al. Prognostic value of lemur tyrosine kinase-3 (LMTK3) polymorphism in Japanese (J) patients (PTS) with localized gastric adenocarcinoma (GAC). Journal of Clinical Oncology. 30: 4088-4088. DOI: 10.1200/JCO.2012.30.15_SUPPL.4088 |
0.01 |
|
| 2012 |
Wakatsuki T, Zhang W, Yang D, Loupakis F, Azuma M, Gerger A, Graziano F, Ning Y, Labonte MJ, El-Khoueiry R, Bohanes PO, Benhaim L, Páez D, Watanabe M, Koizumi W, et al. Ethnic gene profile of genes involved in angiogenesis to predict regional bevacizumab efficacy difference in gastric cancer. Journal of Clinical Oncology. 30: 4026-4026. DOI: 10.1200/JCO.2012.30.15_SUPPL.4026 |
0.01 |
|
| 2012 |
Labonte MJ, Bohanes PO, Yang D, Loupakis F, Wilson PMD, Gerger A, Ning Y, Wakatsuki T, Zhang W, Benhaim L, Ladner RD, El-Khoueiry AB, El-Khoueiry R, Iqbal S, Lenz H. Novel colon cancer tumor suppressor gene, β-defensin 1, to predict recurrence in patients with stage II and III colon cancer. Journal of Clinical Oncology. 30: 3622-3622. DOI: 10.1200/Jco.2012.30.15_Suppl.3622 |
0.01 |
|
| 2012 |
Yang D, Bohanes PO, Zhang W, Harbison C, Trifan OC, Ning Y, Benhaim L, Wakatsuki T, El-Khoueiry AB, Lenz H. Association of HER2 and IGF1 germline polymorphisms with outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with second-line irinotecan (IR) with or without cetuximab (CB): The EPIC experience. Journal of Clinical Oncology. 30: 3615-3615. DOI: 10.1200/JCO.2012.30.15_SUPPL.3615 |
0.01 |
|
| 2012 |
Benhaim L, Loupakis F, Zhang W, Gerger A, Bohanes PO, Páez D, Cremolini C, Wakatsuki T, Yang D, Ning Y, El-Khoueiry R, Zhang H, Salvatore L, Schirripa M, Falcone A, et al. Genetic variants of kinases suppressors of ras in KRAS-BRAF wild-type metastatic colorectal cancer patients treated with cetuximab and irinotecan. Journal of Clinical Oncology. 30: 3597-3597. DOI: 10.1200/JCO.2012.30.15_SUPPL.3597 |
0.01 |
|
| 2012 |
Ladner RD, Gerger A, Zhang W, Labonte MJ, Yang D, Lenz F, Lenz C, Bohanes PO, Ning Y, Winder T, Wilson PMD, Benhaim L, El-Khoueiry R, El-Khoueiry AB, Iqbal S, et al. Association of genetic variants in obesity-related genes with tumor recurrence in stage II/III colon cancer. Journal of Clinical Oncology. 30: 3584-3584. DOI: 10.1200/Jco.2012.30.15_Suppl.3584 |
0.01 |
|
| 2012 |
Loupakis F, Yang D, Zhang W, Cremolini C, Wakatsuki T, Salvatore L, Antoniotti C, Aprile G, Schirripa M, Ricci V, Lucchesi S, Masi G, Maus MKH, Lonardi S, Ning Y, et al. Primary side of origin affects the outcome of mCRC patients treated with first-line FOLFIRI plus bevacizumab independently of BRAF status and mucinous histology. Journal of Clinical Oncology. 30: 3549-3549. DOI: 10.1200/JCO.2012.30.15_SUPPL.3549 |
0.01 |
|
| 2012 |
Schirripa M, Loupakis F, Cremolini C, Yang D, Labonte MJ, Zhang W, Salvatore L, Wakatsuki T, El-Khoueiry R, Antoniotti C, Aprile G, Maus MKH, Lucchesi S, Allegrini G, De Vita F, et al. KSR1 gene polymorphism in mCRC patients treated with first-line FOLFIRI and bevacizumab. Journal of Clinical Oncology. 30: 3546-3546. DOI: 10.1200/JCO.2012.30.15_SUPPL.3546 |
0.01 |
|
| 2012 |
Antoniotti C, Loupakis F, Cremolini C, Zhang W, Yang D, Wakatsuki T, Schirripa M, Salvatore L, Ricci V, Graziano F, Masi G, Ruzzo A, Labonte MJ, Ning Y, El-Khoueiry R, et al. Prospective study of EGFR intron 1 CA tandem repeats to predict factor benefit from cetuximab and irinotecan. Journal of Clinical Oncology. 30: 3540-3540. DOI: 10.1200/JCO.2012.30.15_SUPPL.3540 |
0.01 |
|
| 2012 |
Antoniotti C, Loupakis F, Cremolini C, Zhang W, Yang D, Wakatsuky T, Schirripa M, Salvatore L, Ricci V, Graziano F, Masi G, Labonte MJ, Ning Y, Falcone A, Lenz HJ. P-0263 Prospective Study of Egfr Intron 1 CA Tandem Repeats as Predictive Factor of Benefit from Cetuximab and Irinotecan Annals of Oncology. 23: iv106. DOI: 10.1016/S0923-7534(20)30193-9 |
0.01 |
|
| 2012 |
Cremolini C, Loupakis F, Yang D, Salvatore L, Zhang W, Wakatsuky T, Schirripa M, Lonardi S, Antoniotti C, Aprile G, Masi G, Graziano F, Ruzzo A, Lucchesi S, Maus M, et al. P-0262 Prospective Evaluation of Candidate Snps of Vegf/Vegfr Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line Folfiri Plus Bevacizumab (BV) Annals of Oncology. 23: iv105-iv106. DOI: 10.1016/S0923-7534(20)30192-7 |
0.01 |
|
| 2012 |
Schirripa M, Loupakis F, Cremolini C, Dongyun Y, Labonte MJ, Zhang W, Salvatore L, Wakatsuky T, Antoniotti C, Aprile G, Lucchesi S, Giamas G, Justin S, Falcone A, Lenz HJ. PD-0016 KSR1 Gene Polymorphism in Mcrc Patients Treated with First-Line Folfiri and Bevacizumab Annals of Oncology. 23: iv24. DOI: 10.1016/S0923-7534(19)66510-5 |
0.01 |
|
| 2012 |
Loupakis F, Yang D, Feng S, Cremolini C, Zhang W, Antoniotti C, Langer C, Hurwitz H, Saltz L, Falcone A, Lenz HJ. PD-0009 Primary Tumor Location is a Major Independent Prognostic Factor for Mcrc Patients Annals of Oncology. 23: iv22. DOI: 10.1016/S0923-7534(19)66503-8 |
0.01 |
|
| 2012 |
Loupakis F, Schirripa M, Zhang W, Falcone A, Lenz H. Pharmacogenetic Concerns in Metastatic Colorectal Cancer Therapy Current Colorectal Cancer Reports. 8: 263-271. DOI: 10.1007/s11888-012-0137-2 |
0.01 |
|
| 2011 |
Zhang W, Hu YL. [Forensic clinical analysis on 25 cases of traumatic cerebral infarction]. Fa Yi Xue Za Zhi. 27: 438-40. PMID 22393594 |
0.01 |
|
| 2011 |
Gerger A, Zhang W, Yang D, Bohanes P, Ning Y, Winder T, LaBonte MJ, Wilson PM, Benhaim L, Paez D, El-Khoueiry R, El-Khoueiry A, Kahn M, Lenz HJ. Common cancer stem cell gene variants predict colon cancer recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6934-43. PMID 21918173 DOI: 10.1158/1078-0432.CCR-11-1180 |
0.01 |
|
| 2011 |
Gerger A, El-Khoueiry A, Zhang W, Yang D, Singh H, Bohanes P, Ning Y, Winder T, Labonte MJ, Wilson PM, Benhaim L, Paez D, El-Khoueiry R, Absenger G, Lenz HJ. Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5783-92. PMID 21791631 DOI: 10.1158/1078-0432.CCR-11-1115 |
0.01 |
|
| 2011 |
Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cancer Letters. 310: 35-45. PMID 21763068 DOI: 10.1016/j.canlet.2011.06.001 |
0.01 |
|
| 2011 |
Zhang W, Suguro H, Kobayashi Y, Tsurumachi T, Ogiso B. Effect of canal taper and plugger size on warm gutta-percha obturation of lateral depressions. Journal of Oral Science. 53: 219-24. PMID 21712627 DOI: JST.JSTAGE/josnusd/53.219 |
0.01 |
|
| 2011 |
Hu-Lieskovan S, Vallbohmer D, Zhang W, Yang D, Pohl A, Labonte MJ, Grimminger PP, Hölscher AH, Semrau R, Arnold D, Dellas K, Debucquoy A, Haustermans K, Machiels JP, Sempoux C, et al. EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5161-9. PMID 21673069 DOI: 10.1158/1078-0432.CCR-10-2666 |
0.01 |
|
| 2011 |
Tao R, Li J, Xin J, Wu J, Guo J, Zhang L, Jiang L, Zhang W, Yang Z, Li L. Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma. Plos One. 6: e19862. PMID 21625442 DOI: 10.1371/journal.pone.0019862 |
0.01 |
|
| 2011 |
Giamas G, Filipović A, Jacob J, Messier W, Zhang H, Yang D, Zhang W, Shifa BA, Photiou A, Tralau-Stewart C, Castellano L, Green AR, Coombes RC, Ellis IO, Ali S, et al. Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer. Nature Medicine. 17: 715-9. PMID 21602804 DOI: 10.1038/nm.2351 |
0.01 |
|
| 2011 |
Taki-Eldin A, Zhou L, Xie HY, Chen KJ, Zhou WH, Zhang W, Xing CY, Yang Z, Zhang K, Zheng SS. Tri-iodothyronine enhances liver regeneration after living donor liver transplantation in rats. Journal of Hepato-Biliary-Pancreatic Sciences. 18: 806-14. PMID 21584707 DOI: 10.1007/s00534-011-0397-2 |
0.01 |
|
| 2011 |
Zhang W, Wang JW, Hu YL, Zhu JH. [Comparison of four imaging examinations of shoulder joint injury in forensic expertise]. Fa Yi Xue Za Zhi. 27: 39-42. PMID 21542226 |
0.01 |
|
| 2011 |
Zhang W, Zeng Q, Zhang X, Tian Y, Yue Y, Guo Y, Wang Z. Ligand-free CuO nanospindle catalyzed arylation of heterocycle C-H bonds. The Journal of Organic Chemistry. 76: 4741-5. PMID 21506558 DOI: 10.1021/jo200452x |
0.01 |
|
| 2011 |
Zhang W, Zhou L, Ding SM, Xie HY, Xu X, Wu J, Chen QX, Zhang F, Wei BJ, Eldin AT, Zheng SS. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation. Oncology Reports. 25: 1053-62. PMID 21271221 DOI: 10.3892/or.2011.1159 |
0.01 |
|
| 2011 |
Jiang LJ, Zhang NN, Ding F, Li XY, Chen L, Zhang HX, Zhang W, Chen SJ, Wang ZG, Li JM, Chen Z, Zhu J. RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. Proceedings of the National Academy of Sciences of the United States of America. 108: 1897-902. PMID 21224412 DOI: 10.1073/pnas.1019059108 |
0.01 |
|
| 2011 |
Gordon MA, Zhang W, Yang D, Iqbal S, El-Khouiery A, Nagashima F, Lurje G, Labonte M, Wilson P, Sherrod A, Ladner RD, Lenz HJ. Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin. Pharmacogenomics. 12: 27-39. PMID 21174620 DOI: 10.2217/Pgs.10.163 |
0.01 |
|
| 2011 |
Winder T, Ning Y, Yang D, Zhang W, Power DG, Bohanes P, Gerger A, Wilson PM, Lurje G, Tang LH, Shah M, Lenz HJ. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. International Journal of Cancer. 129: 1096-104. PMID 21105049 DOI: 10.1002/ijc.25787 |
0.01 |
|
| 2011 |
Zhu JH, Hu YL, Zhang W, Guan W, Huang GZ. [Effects of triptolide on hypothalamic-pituitary-adrenal axis of rats]. Fa Yi Xue Za Zhi. 26: 260-5. PMID 20967951 |
0.01 |
|
| 2011 |
Ning Y, Manegold PC, Hong YK, Zhang W, Pohl A, Lurje G, Winder T, Yang D, LaBonte MJ, Wilson PM, Ladner RD, Lenz HJ. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. International Journal of Cancer. Journal International Du Cancer. 128: 2038-49. PMID 20648559 DOI: 10.1002/Ijc.25562 |
0.01 |
|
| 2011 |
Press OA, Zhang W, Gordon MA, Yang D, Haiman CA, Azuma M, Iqbal S, Lenz HJ. Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer. The Pharmacogenomics Journal. 11: 375-82. PMID 20548329 DOI: 10.1038/Tpj.2010.45 |
0.01 |
|
| 2010 |
Zhang W, Wu J, Zhou L, Xie HY, Zheng SS. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian Journal of Experimental Biology. 48: 1167-74. PMID 21250597 |
0.01 |
|
| 2010 |
Zhang W, Azuma M, Lurje G, Gordon MA, Yang D, Pohl A, Ning Y, Bohanes P, Gerger A, Winder T, Hollywood E, Danenberg KD, Saltz L, Lenz HJ. Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study). Anticancer Research. 30: 4209-17. PMID 21036743 |
0.01 |
|
| 2010 |
Winder T, Zhang W, Yang D, Ning Y, Bohanes P, Gerger A, Wilson PM, Pohl A, Mauro DJ, Langer C, Rowinsky EK, Lenz HJ. Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5591-602. PMID 20935157 DOI: 10.1158/1078-0432.CCR-10-2092 |
0.01 |
|
| 2010 |
Gold PJ, Goldman B, Iqbal S, Leichman LP, Zhang W, Lenz HJ, Blanke CD. Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415). Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1472-6. PMID 20631636 DOI: 10.1097/JTO.0b013e3181e77a92 |
0.01 |
|
| 2010 |
Zhang L, Xiao M, Wang Y, Zhang W. Reverse engineering large-scale genetic networks: synthetic versus real data. Journal of Genetics. 89: 73-80. PMID 20505249 DOI: 10.1007/s12041-010-0013-2 |
0.01 |
|
| 2010 |
Li Y, Lee S, Hujoel P, Su M, Zhang W, Kim J, Zhang YP, DeVizio W. Prevalence and severity of gingivitis in American adults. American Journal of Dentistry. 23: 9-13. PMID 20437720 |
0.01 |
|
| 2010 |
Fu CT, Zhu KY, Mi JQ, Liu YF, Murray ST, Fu YF, Ren CG, Dong ZW, Liu YJ, Dong M, Jin Y, Chen Y, Deng M, Zhang W, Chen B, et al. An evolutionarily conserved PTEN-C/EBPalpha-CTNNA1 axis controls myeloid development and transformation. Blood. 115: 4715-24. PMID 20371743 DOI: 10.1182/Blood-2009-11-255778 |
0.01 |
|
| Hide low-probability matches. |